[go: up one dir, main page]

WO2009150888A1 - Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent - Google Patents

Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent Download PDF

Info

Publication number
WO2009150888A1
WO2009150888A1 PCT/JP2009/056803 JP2009056803W WO2009150888A1 WO 2009150888 A1 WO2009150888 A1 WO 2009150888A1 JP 2009056803 W JP2009056803 W JP 2009056803W WO 2009150888 A1 WO2009150888 A1 WO 2009150888A1
Authority
WO
WIPO (PCT)
Prior art keywords
milk protein
degradation product
protein degradation
lactic acid
bifidobacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2009/056803
Other languages
French (fr)
Japanese (ja)
Inventor
金忠 清水
寿美子 米澤
浩 越智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Priority to JP2010516787A priority Critical patent/JPWO2009150888A1/en
Publication of WO2009150888A1 publication Critical patent/WO2009150888A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/20Animal feeding-stuffs from material of animal origin
    • A23K10/26Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • A23K10/28Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21096Lactocepin (3.4.21.96)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Definitions

  • the present invention uses a living lactic acid bacterium having a cell wall-enhanced proteinase (cell wall-enveloped proteinase, PrtP), a disrupted microbial cell of the lactic acid bacterium, an enzyme fraction fractionated from the lactic acid bacterium, and the like.
  • the present invention relates to a protein degradation product to be obtained, a method for producing the protein degradation product, and a bifidobacteria growth promoter comprising the protein degradation product as an active ingredient.
  • Bifidobacterium spp. That is, bifidobacteria, is one of the dominant fungal species of the intestinal flora formed in the human intestinal tract, the intestinal regulating action to restore the balance of intestinal bacteria, It is known to have an immunopotentiating action, a carcinogenesis suppressing action, and the like. For this reason, in recent years, the demand for foods containing living bifidobacteria such as fermented bifidobacteria has increased along with an increase in the health orientation of consumers.
  • Bifidobacteria have poor growth in milky media. For this reason, in order to contain a certain amount of, for example, 1 ⁇ 10 7 CFU / mL bifidobacteria in the fermented milk, usually, various growth promoting substances such as yeast extract are added. However, the growth promoting substance is generally expensive and the flavor may be impaired. For this reason, development of a growth promoter for bifidobacteria that is less expensive and has less influence on the flavor has been demanded.
  • a peptide obtained by pepsin treatment of human milk has a bifidobacteria growth promoting action, and in particular, a pepsin degradation product of human protein lactoferrin has a bifidobacterial growth promoting action.
  • a bifidobacterial growth promoter characterized by comprising (2) actomyosin or a peptide-containing fraction obtained by treating a meat protein suspension containing actomyosin with a protease.
  • actomyosin or a peptide-containing fraction obtained by treating a meat protein suspension containing actomyosin with a protease.
  • the peptide of the above (1) is a protein contained in human milk or human milk, it is difficult to secure the raw material and is not very suitable for industrial use such as addition to food and drink.
  • the bifidobacteria growth promoter of (2) above has no particular problem in securing the raw material because the raw material is meat protein, but since the peptide can be an allergen, it is originally derived from meat such as bifidobacteria fermented milk. It is not preferable to add this bifidobacterial growth promoter to foods and drinks not using protein as a raw material from the viewpoint of food allergy.
  • the present invention is a milk protein degradation product which is excellent in mass productivity and can promote the growth of bifidobacteria without requiring a protein source other than a milk-derived material which is a main culture raw material of bifidobacteria, and the milk protein It aims at providing the manufacturing method of a degradation product, and the bifidobacteria growth promoter which uses this milk protein degradation product as an active ingredient.
  • the present inventors have found that a living lactic acid bacterium having a cell wall-localized proteolytic enzyme PrtP represented by Lactococcus lactis or a microbial cell of the lactic acid bacterium.
  • the present inventors have found that a crushed product and a milk protein degradation product from a cell wall-localized proteolytic enzyme PrtP fraction fractionated from the lactic acid bacteria have a bifidobacteria growth-promoting action, thereby completing the present invention.
  • the present invention provides a living cell of lactic acid bacteria having cell wall-enveloped proteinase (cell wall-enveloped proteinase, PrtP), a crushed cell of the lactic acid bacteria, and the enzyme fraction fractionated from the lactic acid bacteria.
  • the present invention provides a milk protein hydrolyzate obtained by hydrolyzing milk protein using one or more selected from the group consisting of:
  • the present invention also provides the milk protein degradation product as described above, wherein the lactic acid bacterium is Lactococcus lactis.
  • the present invention also provides the milk protein degradation product as described above, wherein the Lactococcus lactis does not have xylose utilization and does not produce diacetyl and acetoin.
  • the present invention provides the milk protein degradation product according to any one of the above, wherein the milk protein is casein or total milk protein.
  • the hydrolysis is performed under the conditions of 20 to 37 ° C. and a milk protein concentration of 0.5% by weight or more using a milk protein adjusted to pH 6.0 to 8.0 as a substrate.
  • the milk protein degradation product according to any one of the above-mentioned features is provided.
  • the present invention also provides a living cell of lactic acid bacteria having cell wall-enhanced proteinase (cell wall-enveloped proteinase, PrtP), a crushed cell of the lactic acid bacteria, and the enzyme fraction fractionated from the lactic acid bacteria.
  • the present invention provides a method for producing a milk protein hydrolyzate, which comprises hydrolyzing milk protein using one or more selected from the group consisting of:
  • the present invention also provides the method for producing a milk protein degradation product as described above, wherein the lactic acid bacterium is Lactococcus lactis. Further, the present invention provides the method for producing a milk protein degradation product as described above, wherein the Lactococcus lactis has no xylose utilization property and does not produce diacetyl and acetoin. It is.
  • the present invention also provides the method for producing a milk protein degradation product according to any one of the above, wherein the milk protein is casein or total milk protein. In the present invention, the hydrolysis is performed under the conditions of 20 to 37 ° C.
  • the present invention provides a method for producing a milk protein degradation product according to any one of the above. Moreover, this invention provides the bifidobacteria growth promoter which uses the milk protein degradation product in any one of the said description as an active ingredient. The present invention also provides the aforementioned bifidobacteria growth promoter, wherein the bifidobacteria is Bifidobacterium longum.
  • the Bifidobacterium longum strain is the Bifidobacterium longum ATCC BAA-999 strain and / or the Bifidobacterium longum type strain ATCC15700 strain. An agent is provided.
  • the milk protein degradation product of the present invention is obtained by hydrolyzing milk protein with a cell wall-localized proteolytic enzyme PrtP derived from lactic acid bacteria, so that it is excellent in mass productivity and manufactured at a relatively low cost. Is also possible. Further, the bifidobacteria growth promoter of the present invention is unprecedented and can grow bifidobacteria, particularly Bifidobacterium longum. Moreover, since the milk protein degradation product which is an active ingredient is a milk-derived substance, the bifidobacteria growth promoter of the present invention is also applied to foods and drinks produced by culturing bifidobacteria with milk-derived raw materials such as fermented milk. It can be used without having to consider protein allergies other than milk protein, and is useful in designing dairy products such as fermented milk.
  • the milk protein degradation product of the present invention includes a living lactic acid bacterium having a cell wall-localized proteolytic enzyme PrtP (hereinafter sometimes simply referred to as “PrtP enzyme”), a crushed cell product of the lactic acid bacterium, and It is obtained by hydrolyzing milk protein using one or more selected from the group consisting of the enzyme fractions fractionated from the lactic acid bacteria. Since the milk protein degradation product of the present invention has a bifidobacteria growth promoting activity, an excellent bifidobacteria growth promoter having a high bifidobacteria growth promoting effect can be obtained by using the milk protein degradation product of the present invention as an active ingredient. Can be obtained. The reason why the milk protein degradation product of the present invention exerts the bifidobacteria growth-promoting effect is not clear. It is guessed that there is not.
  • the lactic acid bacterium used in the present invention has a PrtP enzyme.
  • the PrtP enzyme is an enzyme that exists in the cell membrane and has an active site exposed on the cell surface.
  • Examples of lactic acid bacteria having a PrtP enzyme include Lactococcus lactis subspices cremoris and Lactococcus lactis subspice lactos. In the genus, several strains having PrtP have been reported.
  • PrtP enzymes derived from Lactococcus lactis include P type I (which does not degrade ⁇ -casein very much and ⁇ -casein is degraded well from the vicinity of the C-terminal), type P III ( ⁇ -casein and ⁇ -casein is well resolved from both C-terminus and N-terminus) and its intermediate form (P I / P III type) (eg, Reid, JR. et al., Applied and Environmental Microbiology, 1994).
  • PrtP enzymes derived from Lactococcus lactis include PrtP enzymes whose gene sequences are registered in NCBI (National Center for Biotechnology Information) as accession numbers AY542690, AY5422691, and the like.
  • a certain lactic acid bacterium is a PrtP enzyme-containing lactic acid bacterium (lactic acid bacterium having a PrtP enzyme) has, for example, a PrtP gene encoding a PrtP enzyme using a gene analysis technique such as PCR (Polymerase Chain Reaction). It can be confirmed by examining whether or not.
  • the PrtP enzyme Since the PrtP enzyme has an enzyme active site outside the cell, it can degrade proteins in the medium. For example, when a lactic acid bacterium grows in a milky medium, the PrtP enzyme degrades milk protein in the milky medium, and oligopeptides and amino acids necessary for the growth of the lactic acid bacterium are provided. Therefore, Lactococcus lactis with PrtP enzyme grows so that the medium can be solidified when cultured in a 10% (W / W) reduced skim milk medium at a temperature range of 25-30 ° C. for 16 hours. It is fast and has strong fermentability. PrtP enzyme-containing lactic acid bacteria can also be detected by utilizing such characteristics of high growth and fermentability. In addition, PrtP enzyme-containing lactic acid bacteria can also be detected by detecting PrtP enzyme activity.
  • the lactic acid bacterium used in the present invention is not particularly limited as long as it has a PrtP enzyme, but is preferably a bacterium belonging to the genus Lactococcus, more preferably Lactococcus lactis, and Lactococcus lactis. -Subspecies Cremolis and Lactococcus lactis subspecies lactis are more preferable. This is because dairy products made from bifidobacteria such as fermented milk have been used as raw materials and are considered to be highly safe. Examples of Lactococcus lactis having PrtP enzyme include Lactococcus lactis subspices cremolith NBRC100676 T strain, Lactococcus lactis subspices lactis JCM20101 strain and the like.
  • the medium used for the preculture of the PrtP enzyme-containing lactic acid bacteria is not particularly limited as long as it is a medium that is usually used for culturing Lactococcus lactis, but Difco (registered trademark) M17 Broth (Becton And a commercially available semi-synthetic medium such as Dickinson) or a dairy medium such as a reduced skim milk medium.
  • growth promoting substances such as glucose and yeast extract, reducing agents such as L-cysteine, and the like can be added to the medium used for preculture.
  • the culture medium used for preculture uses what sterilized.
  • the sterilization treatment can be performed by a commonly used method, for example, by heat treatment at 80 to 122 ° C. for 5 to 40 minutes, preferably 85 to 95 ° C. for 5 to 35 minutes.
  • the one used for the hydrolysis of milk protein is not particularly limited as long as the enzyme activity of the PrtP enzyme is maintained, but the live cell of the PrtP enzyme-containing lactic acid bacterium, It is preferable that it is the crushed cell body of lactic acid bacteria, and the PrtP enzyme fraction fractionated from the said lactic acid bacteria.
  • the live cell of the PrtP enzyme-containing lactic acid bacterium used in the present invention may be a lactic acid bacterium cultured by a conventional method as it is, or may be a dry bacterium powder prepared by a conventional method such as lyophilization.
  • the cultured lactic acid bacteria may be used together with the medium used for the culture, or may be one obtained by collecting only the cells from the medium by centrifugation or the like and then suspending them in an appropriate buffer or the like. Since it is possible to remove excess medium and the concentration can be adjusted by concentration or dilution, it is preferable to use a suspension of cells recovered from the medium in a buffer.
  • the buffer for suspending the cells recovered from the medium is not particularly limited as long as it is a solvent that can suspend lactic acid bacteria in a live state, and is usually used for suspending lactic acid bacteria. Although a buffer etc. can be used, it is preferable that it is a buffer containing calcium ion.
  • the pH of the buffer used for the suspension is preferably 4.5 to 8.0. Examples of the buffer include MES buffer, HEPES buffer, and phosphate buffer. In addition, physiological saline may be used.
  • the cell disruption product of the PrtP enzyme-containing lactic acid bacterium used in the present invention is not particularly limited as long as it is obtained by crushing the lactic acid bacterium without impairing the enzyme activity of the PrtP enzyme.
  • a crushing method include a crushing process using ultrasonic waves, a glass bead crushing process, and a crushing process using osmotic shock. These crushing treatments are preferably performed at a low temperature of 50 ° C. or lower, preferably room temperature or lower, more preferably 10 ° C. or lower. This is because the PrtP enzyme is deactivated by heating.
  • the PrtP enzyme fraction fractionated from the PrtP enzyme-containing lactic acid bacterium used in the present invention is obtained by fractionating the PrtP enzyme from the lactic acid bacterium without impairing the enzyme activity of the PrtP enzyme, It is not particularly limited. For example, after culturing the lactic acid bacteria collected from the culture medium after suspending in a buffer, removing the bacterial cells by centrifugation or the like, the supernatant containing the PrtP enzyme released from the cell surface of the lactic acid bacteria, It can be obtained as a PrtP enzyme fraction.
  • a chelating agent such as EDTA
  • a buffer to which a chelating agent such as EDTA is added As a buffer for obtaining such a supernatant, for example, a buffer obtained by adding a chelating agent such as EDTA to the above-mentioned buffers that can be used for suspending viable cells can be used.
  • the temperature at which lactic acid bacteria are retained in the buffer is not particularly limited as long as it is less than 50 ° C., but is preferably about 4 to 37 ° C., more preferably about 30 ° C.
  • the holding time can be appropriately determined in consideration of the holding temperature, the type of buffer, etc., but is preferably within 1 hour, more preferably 5 to 30 minutes, and 5 to 15 minutes. More preferably it is.
  • the chelating agent can be removed from the PrtP enzyme fraction by dialysis of the supernatant thus obtained.
  • the fractionated PrtP enzyme fraction can be concentrated by a known technique such as freeze concentration without impairing the PrtP enzyme activity.
  • it may be a PrtP enzyme fraction obtained by fractionating a crushed bacterial body of lactic acid bacteria using a known fractionation means such as ammonium sulfate precipitation method or chromatography method.
  • the milk protein used in the present invention is not particularly limited as long as it is a milk-derived protein collected from animals such as cows, goats, horses and sheep (excluding humans), and is usually used for food. Milk-derived protein can be appropriately selected and used. In this invention, it is preferable that it is the milk protein contained in the milk with high industrial utility value.
  • the milk protein may be casein, whey protein (protein contained in whey), or total milk protein.
  • the milk protein used in the present invention is preferably casein derived from milk or total milk protein, and more preferably casein derived from milk. This is because a milk protein degradation product having a higher bifidobacteria growth promoting effect can be obtained.
  • milk proteins such as casein, total milk protein, and whey protein, those prepared by a conventional method can be used. Moreover, you may use what is marketed.
  • the milk protein degradation product of the present invention is one or more selected from the group consisting of a milk protein, a living cell of a PrtP enzyme-containing lactic acid bacterium, a crushed cell of the lactic acid bacterium, and a PrtP enzyme fraction fractionated from the lactic acid bacterium. It is obtained by adding and hydrolyzing.
  • the added PrtP enzyme-containing lactic acid bacteria live cells, crushed cell bodies, and PrtP enzyme fractions are preferably added as prepared by appropriately freeze-concentrating or lyophilizing those prepared as described above.
  • the hydrolysis reaction conditions are not particularly limited as long as the enzymatic reaction can be performed by the PrtP enzyme, and may be appropriately determined in consideration of the type of PrtP enzyme, the type of milk protein, and the like. it can.
  • the PrtP enzyme can be expected to have enzyme activity under conditions that are substantially equivalent to the environment in which the derived lactic acid bacteria can grow (proliferate).
  • the reaction temperature in the hydrolysis is preferably less than 50 ° C., more preferably 10 to 42 ° C., further preferably 20 to 37 ° C., and about 30 ° C. Particularly preferred.
  • the milk protein to be subjected to hydrolysis is preferably adjusted to pH 6.0 to 8.0, more preferably adjusted to 6.0 to 7.5. More preferably, it is adjusted to around 5.
  • the pH of the milk protein that is the substrate is 6.0 or more, protein aggregation hardly occurs when the obtained milk protein degradation product is heat-sterilized.
  • the pH of milk protein is 8.0 or less, protein denaturation hardly occurs when the obtained milk protein degradation product is heat sterilized.
  • the milk protein concentration in the reaction system in the hydrolysis can be appropriately determined in consideration of the desired milk protein degradation product concentration, the amount of PrtP enzyme to be added, the reaction time, and the like.
  • the milk protein concentration in the hydrolysis is preferably 0.5% by weight or more, and more preferably 1% by weight or more. This is because a milk protein degradation product with more excellent bifidobacteria growth promoting ability can be obtained.
  • the amount of the PrtP enzyme-containing lactic acid bacterium live cells, crushed cells, and PrtP enzyme fraction added to the reaction system in the hydrolysis is determined in consideration of the amount of milk protein to be added and the like. Although it can determine suitably, it is preferable to add so that it may become 1 Unit / ml or more as a unit of the PrtP enzyme activity mentioned later.
  • the hydrolysis reaction time can be appropriately determined in consideration of the reaction temperature, milk protein concentration, the amount of PrtP enzyme to be added, and the like. For example, the addition amount of live cells of PrtP enzyme-containing lactic acid bacteria will be described later.
  • the unit of PrtP enzyme activity is 3.5 Unit / ml and the reaction temperature is 30 ° C., it is preferably 5 hours or longer.
  • the milk protein degradation product obtained by hydrolysis may use the reaction solution after the reaction as it is, but after the reaction, the PrtP enzyme in the reaction solution is inactivated by heat treatment or the like. It is preferable.
  • the bifidobacteria growth promoter of the present invention contains the milk protein degradation product produced as described above as an active ingredient.
  • milk-derived ingredients produced as active ingredients
  • food and drink produced by culturing bifidobacteria with milk-derived raw materials such as fermented milk should be used without considering protein allergies other than milk proteins. Can do.
  • the amount of the milk protein degradation product of the present invention contained in the bifidobacteria growth promoter of the present invention is not particularly limited as long as the bifidobacteria growth promoting effect is obtained, but it may be 10% by weight or more. It is preferably 15% by weight or more, more preferably 20% by weight or more, and particularly preferably 40% by weight or more.
  • the dosage form of the Bifidobacterium growth promoter of the present invention is not particularly limited, and may be a powder such as a lyophilized product, a tablet, a liquid, or a paste. There may be.
  • the bifidobacteria growth promoter of this invention may contain the other component, unless the bifidobacteria growth promotion effect by the milk protein degradation product of this invention is inhibited. Examples of other components include commonly added adjuvants and stabilizers such as starch and lactose.
  • a known substance having a bifidobacteria growth promoting action may be added.
  • the bifidobacteria growth promoter of the present invention can exert a bifidobacteria growth promoting effect by adding it to a culture medium of bifidobacteria.
  • the amount to be added to the culture medium is not particularly limited as long as the effect of promoting the growth of bifidobacteria is obtained.
  • the amount of milk protein degradation product in the bifidobacteria growth promoter, the composition of the culture medium of bifidobacteria, and the starter It can be determined as appropriate in consideration of the inoculation amount of a certain bifidobacteria, the type of bifidobacteria and the like.
  • the bifidobacteria growth promoter of the present invention is preferably added so as to be 0.01 to 10 (V / V)%, for example, 0.1 to 5 (V / V)% is particularly preferable.
  • the culture medium for bifidobacteria to which the agent for promoting growth of bifidobacteria of the present invention is added is not particularly limited as long as it is a commonly used medium. You can choose.
  • the fermenting base used for producing bifidobacteria fermented milk is not particularly limited as long as it is a base usually used for producing fermented milk.
  • the base is, for example, milk, skim milk, fresh cream, butter, whole milk powder, skim milk powder, sweeteners such as sucrose, pectin, fruit, fruit juice, agar, gelatin, oil, fat, flavor, coloring It can be prepared by blending a material, a stabilizer, a reducing agent, etc., and sterilizing, homogenizing, cooling and the like according to a conventional method.
  • the bifidobacteria to which the bifidobacteria growth promoter of the present invention is added can be those pre-cultured by a conventional method.
  • the culture medium used for pre-culture of bifido is not particularly limited as long as it is a commonly used medium, but is preferably a milky medium.
  • a reduced skim milk medium is particularly preferred because of easy handling.
  • the concentration of the reduced skim milk medium is preferably 3% (W / W) or more, particularly preferably 8% (W / W) or more.
  • growth-promoting substances such as yeast extract, reducing agents such as L-cysteine, and the like can be added to the medium used for preculture.
  • a medium to which a growth promoting substance is added For example, a medium containing 0.1 to 1% (W / W) yeast extract can be used.
  • the culture medium used for preculture uses what sterilized.
  • the sterilization treatment can be performed by a commonly used method, for example, by heat treatment at 80 to 122 ° C. for 5 to 40 minutes, preferably 85 to 95 ° C. for 5 to 35 minutes.
  • the growth target bacterium of the Bifidobacterium growth promoter of the present invention is not particularly limited as long as it is a Bifidobacterium, but is preferably Bifidobacterium longum. This is because the growth promoting effect of the milk protein degradation product of the present invention can be obtained more significantly.
  • Bifidobacterium longum ATCC BAA-999 strain and Bifidobacterium longum type strain ATCC15700 strain are preferable.
  • the bifidobacteria growth promoter of the present invention is capable of growing bifidobacteria, particularly Bifidobacterium longum, which has never existed before, the use of the bifidobacteria growth promoter of the present invention makes it more effective in regulating the intestine. It is possible to produce foods and beverages containing bifidobacteria such as bifidobacteria fermented milk, which are high in health and useful for health care.
  • the primer used was a primer set of forward primer GBf (GCAAATACGGTGACGGCTGGCGA) and reverse primer GB2r (TGAGCATTATAATAGGTCTTTCTTCC), or forward primer GHf (CAAATACGGTGACGCGCTGCTAAA) and reverse primer GH2r (TAGCATTATATAGTGTG).
  • FIG. 1 is a diagram showing band patterns obtained by separating PCR products by electrophoresis and detecting them by staining.
  • “1” is a lane in which a molecular weight marker is passed
  • “2” is a PCR product of Lactococcus lactis subspecies Cremolis NBRC100676 T strain
  • “3” is Lactococcus lactis subspices lactis.
  • PCR product of JCM20101 strain “4” is a PCR product of Lactococcus lactis subspecies lactis NBRC 12007 strain, “5” is a PCR product of Lactococcus lactis subspecies lactis JCM20128 strain, “6” is a lactococcus -Lanes in which PCR products of Lactis subspecies Cremolis ATCC-9625 strain were respectively flowed.
  • Lactococcus lactis sub-species Cremolis NBRC100676 T strain and Lactococcus lactis sub-species lactis JCM20101 strain possessed the PrtP gene.
  • Lactococcus lactis subspecies Cremolis ATCC-9625 strain, Lactococcus lactis subspices lactis NBRC12007 strain and Lactococcus lactis subspices lactis JCM20128 strain each possesses Not found out.
  • PrtP Enzyme Activity 0.4 ml of 30 mM MES-NaOH buffer (pH 6.5) containing 0.02% FTC-casein was added to 0.1 ml of a commercial proteolytic enzyme trypsin solution (manufactured by Sigma, enzyme activity). 11,100 Unit / mg) was added and reacted at 30 ° C. for 1 hour. 1.2 ml of 5% trichloroacetic acid was added, mixed by vortexing, and allowed to stand at room temperature for 15 minutes.
  • the fluorescence intensity value obtained by decomposing one unit of trypsin was converted into a PrtP enzyme in the case of degrading with a live cell of Lactococcus lactis having a PrtP enzyme gene, a crushed cell or a PrtP enzyme fraction.
  • One enzyme unit of activity was defined.
  • the cells were washed twice with 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM calcium chloride, suspended in the same buffer, and washed cells (live cells) concentrated 10 times. Moreover, the heat processing for 10 minutes were performed at 90 degreeC with respect to a part of microbial cell. Next, 1% of viable cells or heat-treated cells was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and the mixture was maintained at 30 ° C. for 24 hours with gentle stirring. After the reaction, it was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected solution was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/50 volume by freeze concentration.
  • Measurement of bifidobacteria growth-promoting activity 4-1 Measurement of the number of bifidobacteria The medium containing total milk protein 5% (W / W) and lactose 5% (W / W) was sterilized at 90 ° C. for 10 minutes, as described above. A fixed amount of casein degradation product of each prepared strain of Lactococcus lactis was added, inoculated with 0.1% culture of Bifidobacterium longum ATCC BAA-999 strain, and cultured at 37 ° C. for 16 hours. . After cultivation, the number of bifidobacteria was measured by a serial dilution method using a TOS propionic acid agar medium (manufactured by Yakult Pharmaceutical Co., Ltd.).
  • a culture of Bifidobacterium longum ATCC BAA-999 strain was prepared as described in Example 1 below.
  • a medium containing 5% (W / W) total milk protein and 5% (W / W) lactose was sterilized at 90 ° C. for 10 minutes, and the bacterial cells of each strain of Lactococcus lactis prepared as described above.
  • 1% of the casein degradation product and 0.1% culture of Bifidobacterium longum ATCC BAA-999 strain were inoculated and cultured at 37 ° C. for 16 hours. The culture was rapidly cooled, and the number of bifidobacteria and pH were measured. The measurement results are shown in Table 1.
  • the casein degradation product of the Lactococcus lactis subspices cremolith NBRC100676 strain and the Lactococcus lactis subspices lactis JCM20101 strain having the PrtP enzyme gene has a pH of 5.
  • the number decreased to 0 or less, and the number of bifidobacteria reached around 3 ⁇ 10 8 CFU / g.
  • each of Lactococcus lactis subspecies Cremolis ATCC-9625 strain, Lactococcus lactis subspices lactis NBRC12007 strain, and Lactococcus lactis subspices lactis strain JCM20128 not having a PrtP enzyme gene When the casein degradation product was added by viable cells, the pH was 5.5 or more and the number of bifidobacteria was 5 ⁇ 10 7 CFU / g or less, which was not significantly different from the non-treated control. On the other hand, the casein degradation product by heat-treated cells did not show the bifidobacteria growth promoting activity.
  • the milk protein degradation product by the living strain of Lactococcus lactis having the PrtP enzyme gene has growth promoting ability against Bifidobacteria. Since the casein degradation product of Lactococcus lactis subspecies lactis JCM20101 strain showed stronger bifidobacteria growth promoting activity, the degradation conditions were examined using the JCM20101 strain.
  • washed cells (PrtP enzyme-containing living cells) of Lactococcus lactis subspecies lactis JCM20101 strain were obtained.
  • 3.5 unit / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and gently stirred at 30 ° C. for 24 hours. Retained.
  • the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation.
  • the collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
  • a commercial proteolytic enzyme trypsin manufactured by Sigma was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein at a rate of 3.5 Units / ml. went. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
  • PrtP enzyme activity As described in 3 above, washed cells (PrtP enzyme-containing live cells) of Lactococcus lactis sub-species lactis JCM20101 strain were obtained. Next, 0.01 to 10 Units / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein at 30 ° C. with gentle stirring. Hold for 24 hours. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation.
  • Tris-HCl buffer pH 6.5
  • the collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
  • Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 5.
  • the bifidobacteria growth-promoting action by each degradation product became stronger depending on the PrtP enzyme activity, and a stronger bifidobacteria growth-promoting activity was observed with an enzyme activity of 1 Units / ml or more.
  • the collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
  • Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 6.
  • the bifidobacteria growth-promoting action of each degradation product was observed to be bifidobacteria growth-promoting activity at a casein protein concentration of 0.5% or more, and particularly stronger at a concentration of 1% or more.
  • PrtP enzyme-containing disrupted cells As described in 3 above, washed cells of Lactococcus lactis sub-species lactis JCM20101 strain were obtained. Subsequently, the washed cells are subjected to ultrasonic crushing treatment for 10 minutes or more using an ultrasonic crusher (BRANSON SOFIER 450) to crush the cells, and then centrifuged (5000 ⁇ g, 10 minutes). Unbroken cells were removed to obtain crushed cells. In addition, it was confirmed by microscopic observation and colony culture that there were no living cells in the crushed cells.
  • BRANSON SOFIER 450 ultrasonic crusher
  • Degradation activity by PrtP enzyme fraction As described in 3 above, washed bacterial cells of Lactococcus lactis subspecies lactis JCM20101 strain were obtained. Subsequently, the washed cells were suspended in 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM EDTA ⁇ 2Na and kept at 30 ° C. for 10 minutes. Thereafter, it was rapidly cooled to obtain a supernatant containing PrtP enzyme released by centrifugation at 4 ° C. (8500 ⁇ g, 10 minutes).
  • This PrtP enzyme fraction was dialyzed overnight against 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM calcium chloride, and then concentrated to 1/50 volume by freeze concentration, and this was used as the PrtP enzyme fraction.
  • 1 unit / ml of this PrtP enzyme fraction was added as a PrtP enzyme unit to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and the mixture was kept at 30 ° C. for 16 hours with gentle stirring.
  • heat treatment was performed at 90 ° C. for 10 minutes, the pH was adjusted to 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation.
  • the living cells of the Lactococcus lactis subspices cremolith NBRC100676 strain and Lactococcus lactis subspices lactis JCM20101 strain having the PrtP enzyme gene, and milk from the PrtP enzyme fraction It was revealed that the protein degradation product has a growth promoting activity against bifidobacteria. Moreover, it turned out that the activity is stronger than the decomposition product by a general commercial proteolytic enzyme.
  • Lactococcus lactis having these PrtP enzyme genes does not produce diacetyl and acetoin, it can be expected that a savory fermented product can be produced by using these lactic acid bacteria.
  • a Bifidobacterium starter is added to a living cell of Lactococcus lactis having these PrtP enzyme genes, a crushed cell of a cell, or a milk protein degradation product from a PrtP enzyme fraction. And may be fermented.
  • Example 1 Preparation 1 of casein degradation product using live cells containing PrtP enzyme
  • 100 L of Difco (registered trademark) M17 Broth (Becton, Dickinson) added with 0.5% lactose and glucose was sterilized for 15 minutes at 121 ° C. 3 L of culture was inoculated and cultured at 30 ° C. for 16 hours.
  • live cells containing PrtP enzyme were obtained by centrifugation (8500 ⁇ g, 10 minutes, 4 ° C.).
  • the obtained PrtP enzyme-containing viable cells were added to 100 L of a 10% casein (fontera) solution, and kept at 30 ° C. for 24 hours with gentle stirring.
  • heat sterilization treatment was performed at 90 ° C. for 10 minutes, and 10.5 kg of casein decomposition product was obtained by freeze-drying.
  • Example 2 Preparation 2 of casein degradation product using live cells containing PrtP enzyme 11 kg of casein degradation product was used in the same manner as in Example 1 except that the seed culture of Lactococcus lactis sub-species Lactis JCM20101 strain was used instead of the seed culture of Lactococcus lactis sub-species Cremolis NBRC100676 strain. Obtained.
  • Example 3 Preparation 1 of casein degradation product using PrtP enzyme-containing crushed cells First, 100 L of Difco (registered trademark) M17 Broth (Becton, Dickinson) added with 0.5% lactose and glucose was sterilized for 15 minutes at 121 ° C. 3 L of culture was inoculated and cultured at 30 ° C. for 16 hours. Subsequently, the cells were obtained by centrifugation (8500 ⁇ g, 10 minutes, 4 ° C.). Next, the cells were crushed by ultrasonic treatment (BRANSON SOFIER 450, 10 minutes crushing) for 30 minutes, and then centrifuged (8500 ⁇ g, 10 minutes, 4 ° C.) to remove unbroken cells.
  • Difco registered trademark
  • M17 Broth Becton, Dickinson
  • PrtP enzyme-containing microbial cell disruption product was obtained.
  • the obtained PrtP enzyme-containing microbial cell disruption was added to 100 L of 10% casein (Fontera) solution, and kept at 30 ° C. for 24 hours with gentle stirring.
  • heat sterilization treatment was performed at 90 ° C. for 10 minutes, and 10 kg of casein decomposition product was obtained by freeze-drying.
  • Example 4 Preparation 2 of casein degradation product using crushed cell containing PrtP enzyme 9. Casein degradation product in the same manner as in Example 3 except that the seed culture of Lactococcus lactis subspices lactis JCM20101 strain was used instead of the seed culture of Lactococcus lactis subspecies Cremolis NBRC100676 strain. 1 kg was obtained.
  • Example 5 Preparation 1 of casein degradation product by PrtP enzyme fraction 1 First, 100 L of Difco (registered trademark) M17 Broth (Becton, Dickinson) added with 0.5% lactose and glucose was sterilized for 15 minutes at 121 ° C. 3 L of culture was inoculated and cultured at 30 ° C. for 16 hours. Subsequently, the cells were obtained by centrifugation (8500 ⁇ g, 10 minutes, 4 ° C.). Next, this microbial cell was suspended in 30 mM MES-NaOH buffer (pH 6.5) containing 5 L of 10 mM EDTA ⁇ 2Na and kept at 30 ° C. for 10 minutes.
  • Difco registered trademark
  • M17 Broth Becton, Dickinson
  • PrtP enzyme fraction was added to 100 L of 10% casein (Fontera) solution, and the mixture was kept at 30 ° C. for 24 hours with gentle stirring. After the reaction, sterilization was performed at 90 ° C. for 10 minutes, and freeze-dried to obtain 10.1 kg of casein degradation product.
  • Example 6 Preparation 2 of casein degradation product by PrtP enzyme fraction 2 9. Casein degradation product in the same manner as in Example 5 except that the seed culture of Lactococcus lactis subspices lactis JCM20101 strain was used instead of the seed culture of Lactococcus lactis subspecies Cremolis NBRC100676 strain. 1 kg was obtained.
  • Example 7 Preparation of bifidobacteria starter by casein degradation product from PrtP enzyme-containing living cells
  • the casein degradation product prepared by the method described in Example 1 is 0.1% (W / W).
  • 1000 mL of the medium containing the added 10% (W / W) nonfat dry milk was sterilized at 90 ° C. for 30 minutes.
  • 100 mL of a seed culture of Bifidobacterium longum ATCC BAA-999 strain was inoculated and cultured at 37 ° C. for 5 hours to obtain a culture.
  • the pH of the obtained culture was 4.7, and the number of bifidobacteria was 1.2 ⁇ 10 9 CFU / g.
  • Example 8 Preparation of an intestinal preparation by casein degradation product using PrtP enzyme-containing living cells
  • 1 kg of casein degradation product prepared by the method described in Example 2 above was added to 59 kg of dry sterilized starch and 40 kg of sugar, and mixed uniformly. As a result, about 100 kg of an intestinal preparation was obtained.
  • Example 9 Preparation of beverage by casein degradation product using PrtP enzyme-containing living cells 1 kg of casein degradation product prepared by the method described in Example 1 above was added to 100 kg of apple juice, and sterilized at 140 ° C for 2 seconds. Filled into a PET bottle, the milk protein decomposed product-containing beverage of the present invention was obtained.
  • This beverage is a beverage that can be expected to have a bifidobacteria growth action.
  • Example 10 Preparation of feed by casein degradation product with live PrtP enzyme-containing cells 1 kg of casein degradation product prepared by the method described in Example 2 above is added to 100 kg of skim milk powder and mixed uniformly. About 100 kg was obtained as a feed containing a milk protein degradation product.
  • Example 11 Preparation of Total Milk Protein Degradation Product Using PrtP Enzyme-Containing Live Bacteria
  • Lactococcus lactis Prtis PrtP enzyme-containing viable cells were obtained using the seed culture of Subspecies lactis JCM20101 strain.
  • the obtained PrtP enzyme-containing viable cells were added to 100 L of a 10% total milk protein (Mirai) solution, and kept at 30 ° C. for 24 hours with gentle stirring. After the reaction, heat sterilization treatment was performed at 90 ° C. for 10 minutes, and 10.2 kg of total milk protein degradation product was obtained by lyophilization.
  • the milk protein degradation product of the present invention Since the milk protein degradation product of the present invention has bifidobacteria growth-promoting activity, it can be used in the field of manufacturing foods and beverages containing bifidobacteria such as fermented milk containing bifidobacteria.
  • the milk protein degradation product of the present invention uses milk protein such as cow milk as a raw material, the use of the milk protein degradation product of the present invention makes it possible to design a bifidobacteria-containing product using only a milk product. Therefore, it can be used particularly in the field of dairy products.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Provided are a milk protein degradation product that has excellent mass producibility and requires no protein source other than a milk-derived starting material that is the main culture starting material for bifidobacterium and can promote growth of bifidobacterium, a method for manufacturing said milk protein degradation product, and a bifidobacterial growth-promoting agent that has said milk protein degradation product as the active ingredient. Disclosed are a milk protein degradation product that is obtained by hydrolyzing milk protein using 1 or more selected from a group consisting of live lactobacillus cells comprising cell wall-localized protease (cell wall-enveloped proteinase, PrtP), disrupted cells of the above lactobacillus, and a fraction of the above enzyme fractionated from the above lactobacillus, a method for manufacturing said milk protein degradation product and a bifidobacterial growth-promoting agent having said milk protein degradation product as the active ingredient.

Description

乳タンパク質分解物、乳タンパク質分解物の製造方法及びビフィズス菌増殖促進剤Milk protein degradation product, milk protein degradation product production method and bifidobacteria growth promoter

 本発明は、細胞壁局在性タンパク質分解酵素 (cell wall-enveloped proteinase、PrtP)を有する乳酸菌の生菌体、前記乳酸菌の破砕菌体、及び前記乳酸菌から分画された酵素画分等を用いて得られるタンパク質分解物、該タンパク質分解物の製造方法、及び、該タンパク質分解物を有効成分とするビフィズス菌増殖促進剤に関する。
 本願は、2008年6月11日に、日本に出願された特願2008-152951号に基づき優先権を主張し、その内容をここに援用する。
The present invention uses a living lactic acid bacterium having a cell wall-enhanced proteinase (cell wall-enveloped proteinase, PrtP), a disrupted microbial cell of the lactic acid bacterium, an enzyme fraction fractionated from the lactic acid bacterium, and the like. The present invention relates to a protein degradation product to be obtained, a method for producing the protein degradation product, and a bifidobacteria growth promoter comprising the protein degradation product as an active ingredient.
This application claims priority based on Japanese Patent Application No. 2008-15951 filed in Japan on June 11, 2008, the contents of which are incorporated herein by reference.

 ビフィドバクテリウム(Bifidobacterium)属菌、すなわちビフィズス菌は、ヒトの腸管内で形成される腸内菌叢の優勢菌種の一つであり、腸内細菌のバランスを回復する整腸作用や、免疫増強作用、発ガン抑制作用等を有することが知られている。
 このため、近年、生活者の健康志向の高まりと共に、ビフィズス菌発酵乳等の生きているビフィズス菌を含む食品への需要が高まっている。
Bifidobacterium spp., That is, bifidobacteria, is one of the dominant fungal species of the intestinal flora formed in the human intestinal tract, the intestinal regulating action to restore the balance of intestinal bacteria, It is known to have an immunopotentiating action, a carcinogenesis suppressing action, and the like.
For this reason, in recent years, the demand for foods containing living bifidobacteria such as fermented bifidobacteria has increased along with an increase in the health orientation of consumers.

 ビフィズス菌は、乳性培地における増殖性が悪い。このため、発酵乳中に一定量の、例えば1×10CFU/mLのビフィズス菌を含有させるために、通常、酵母エキス等の様々な増殖促進物質を添加することが行われている。しかし、該増殖促進物質は一般的に高価であり、かつ、風味が損なわれるおそれもある。このため、より安価であり、かつ風味に対する影響が小さいビフィズス菌の増殖促進剤の開発が求められている。 Bifidobacteria have poor growth in milky media. For this reason, in order to contain a certain amount of, for example, 1 × 10 7 CFU / mL bifidobacteria in the fermented milk, usually, various growth promoting substances such as yeast extract are added. However, the growth promoting substance is generally expensive and the flavor may be impaired. For this reason, development of a growth promoter for bifidobacteria that is less expensive and has less influence on the flavor has been demanded.

 例えば、(1)ヒト乳をペプシン処理して得られたペプチドに、ビフィズス菌増殖促進作用があること、特に、ヒトタンパク質ラクトフェリンのペプシン分解物に、ビフィズス菌増殖促進作用があることが報告されている(例えば、非特許文献1参照。)。また、(2)アクトミオシン又はアクトミオシンを含む食肉タンパク質懸濁液をプロテアーゼで処理することにより得られるペプチド含有画分を有効成分とすることを特徴とするビフィズス菌増殖促進剤に係る発明が開示されている(例えば、特許文献1参照。)。
リープケ(Liepke,C.)、他5名、ヨーロピアン・ジャーナル・オブ・バイオケミストリー(European Journal of Biochemistry)、2002年、第269巻、第712~718ページ。 特開2007-189914号公報
For example, (1) it has been reported that a peptide obtained by pepsin treatment of human milk has a bifidobacteria growth promoting action, and in particular, a pepsin degradation product of human protein lactoferrin has a bifidobacterial growth promoting action. (For example, see Non-Patent Document 1). Also disclosed is an invention relating to a bifidobacterial growth promoter characterized by comprising (2) actomyosin or a peptide-containing fraction obtained by treating a meat protein suspension containing actomyosin with a protease. (For example, refer to Patent Document 1).
Liepke, C., 5 others, European Journal of Biochemistry, 2002, volume 269, pages 712-718. JP 2007-189914 A

 しかしながら、上記(1)のペプチドは、原料がヒト乳やヒト乳に含有されているタンパク質であるため、原料の確保が困難であり、飲食品に添加する等の産業利用にはあまり適さない。一方、上記(2)のビフィズス菌増殖促進剤は、原料が食肉タンパク質であるため、原料の確保には特に問題はないが、ペプチドはアレルゲンとなり得ることから、ビフィズス菌発酵乳等の元々食肉由来タンパク質を原料としていない飲食品にこのビフィズス菌増殖促進剤を添加することは、食品アレルギーに対する配慮の点から好ましくない。 However, since the peptide of the above (1) is a protein contained in human milk or human milk, it is difficult to secure the raw material and is not very suitable for industrial use such as addition to food and drink. On the other hand, the bifidobacteria growth promoter of (2) above has no particular problem in securing the raw material because the raw material is meat protein, but since the peptide can be an allergen, it is originally derived from meat such as bifidobacteria fermented milk. It is not preferable to add this bifidobacterial growth promoter to foods and drinks not using protein as a raw material from the viewpoint of food allergy.

 本発明は、量産性に優れており、かつ、ビフィズス菌の主要な培養原料である乳由来原料以外のタンパク質源を要することなく、ビフィズス菌の増殖を促進し得る乳タンパク質分解物、該乳タンパク質分解物の製造方法、及び該乳タンパク質分解物を有効成分とするビフィズス菌増殖促進剤を提供することを目的とする。 The present invention is a milk protein degradation product which is excellent in mass productivity and can promote the growth of bifidobacteria without requiring a protein source other than a milk-derived material which is a main culture raw material of bifidobacteria, and the milk protein It aims at providing the manufacturing method of a degradation product, and the bifidobacteria growth promoter which uses this milk protein degradation product as an active ingredient.

 本発明者らは、上記課題を解決すべく鋭意研究した結果、ラクトコッカス・ラクチス(Lactococcus lactis)に代表される細胞壁局在性タンパク質分解酵素PrtPを有する乳酸菌の生菌体や前記乳酸菌の菌体破砕物、前記乳酸菌から分画された細胞壁局在性タンパク質分解酵素PrtP画分による乳タンパク質分解物が、ビフィズス菌増殖促進作用を有することを見出し、本発明を完成させた。 As a result of diligent research to solve the above-mentioned problems, the present inventors have found that a living lactic acid bacterium having a cell wall-localized proteolytic enzyme PrtP represented by Lactococcus lactis or a microbial cell of the lactic acid bacterium. The present inventors have found that a crushed product and a milk protein degradation product from a cell wall-localized proteolytic enzyme PrtP fraction fractionated from the lactic acid bacteria have a bifidobacteria growth-promoting action, thereby completing the present invention.

 すなわち、本発明は、細胞壁局在性タンパク質分解酵素(cell wall-enveloped proteinase、PrtP)を有する乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画された前記酵素画分からなる群より選択される1以上を用いて、乳タンパク質を加水分解することにより得られることを特徴とする乳タンパク質分解物を提供するものである。
 また、本発明は、前記乳酸菌がラクトコッカス・ラクチス(Lactococcus lactis)である前記記載の乳タンパク質分解物を提供するものである。
 また、本発明は、前記ラクトコッカス・ラクチスが、キシロース資化性を有さず、かつ、ダイアセチル及びアセトインを生成しないことを特徴とする前記記載の乳タンパク質分解物を提供するものである。
 また、本発明は、前記乳タンパク質が、カゼイン又はトータルミルクプロテインであることを特徴とする、前記いずれか記載の乳タンパク質分解物を提供するものである。
 また、本発明は、前記加水分解が、pH6.0~8.0に調整された乳タンパク質を基質として、20~37℃、乳タンパク質濃度が0.5重量%以上の条件で行われることを特徴とする、前記いずれか記載の乳タンパク質分解物を提供するものである。
 また、本発明は、細胞壁局在性タンパク質分解酵素 (cell wall-enveloped proteinase、PrtP)を有する乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画された前記酵素画分からなる群より選択される1以上を用いて、乳タンパク質を加水分解することを特徴とする、乳タンパク質分解物の製造方法を提供するものである。
 また、本発明は、前記乳酸菌がラクトコッカス・ラクチス(Lactococcus lactis)である前記記載の乳タンパク質分解物の製造方法を提供するものである。
 また、本発明は、前記ラクトコッカス・ラクチスが、キシロース資化性を有さず、かつ、ダイアセチル及びアセトインを生成しないことを特徴とする前記記載の乳タンパク質分解物の製造方法を提供するものである。
 また、本発明は、前記乳タンパク質が、カゼイン又はトータルミルクプロテインであることを特徴とする、前記いずれか記載の乳タンパク質分解物の製造方法を提供するものである。
 また、本発明は、前記加水分解が、pH6.0~8.0に調整された乳タンパク質を基質として、20~37℃、乳タンパク質濃度が0.5重量%以上の条件で行われることを特徴とする、前記いずれか記載の乳タンパク質分解物の製造方法を提供するものである。
 また、本発明は、前記いずれか記載の乳タンパク質分解物を有効成分とするビフィズス菌増殖促進剤を提供するものである。
 また、本発明は、前記ビフィズス菌がビフィドバクテリウム・ロンガム(Bifidobacterium longum)である前記記載のビフィズス菌増殖促進剤を提供するものである。
 また、本発明は、前記ビフィドバクテリウム・ロンガムの菌株が、ビフィドバクテリウム・ロンガムATCC BAA-999株及び/又はビフィドバクテリウム・ロンガム タイプストレインATCC15700株である前記記載のビフィズス菌増殖促進剤を提供するものである。
That is, the present invention provides a living cell of lactic acid bacteria having cell wall-enveloped proteinase (cell wall-enveloped proteinase, PrtP), a crushed cell of the lactic acid bacteria, and the enzyme fraction fractionated from the lactic acid bacteria. The present invention provides a milk protein hydrolyzate obtained by hydrolyzing milk protein using one or more selected from the group consisting of:
The present invention also provides the milk protein degradation product as described above, wherein the lactic acid bacterium is Lactococcus lactis.
The present invention also provides the milk protein degradation product as described above, wherein the Lactococcus lactis does not have xylose utilization and does not produce diacetyl and acetoin.
In addition, the present invention provides the milk protein degradation product according to any one of the above, wherein the milk protein is casein or total milk protein.
In the present invention, the hydrolysis is performed under the conditions of 20 to 37 ° C. and a milk protein concentration of 0.5% by weight or more using a milk protein adjusted to pH 6.0 to 8.0 as a substrate. The milk protein degradation product according to any one of the above-mentioned features is provided.
The present invention also provides a living cell of lactic acid bacteria having cell wall-enhanced proteinase (cell wall-enveloped proteinase, PrtP), a crushed cell of the lactic acid bacteria, and the enzyme fraction fractionated from the lactic acid bacteria. The present invention provides a method for producing a milk protein hydrolyzate, which comprises hydrolyzing milk protein using one or more selected from the group consisting of:
The present invention also provides the method for producing a milk protein degradation product as described above, wherein the lactic acid bacterium is Lactococcus lactis.
Further, the present invention provides the method for producing a milk protein degradation product as described above, wherein the Lactococcus lactis has no xylose utilization property and does not produce diacetyl and acetoin. It is.
The present invention also provides the method for producing a milk protein degradation product according to any one of the above, wherein the milk protein is casein or total milk protein.
In the present invention, the hydrolysis is performed under the conditions of 20 to 37 ° C. and a milk protein concentration of 0.5% by weight or more using a milk protein adjusted to pH 6.0 to 8.0 as a substrate. The present invention provides a method for producing a milk protein degradation product according to any one of the above.
Moreover, this invention provides the bifidobacteria growth promoter which uses the milk protein degradation product in any one of the said description as an active ingredient.
The present invention also provides the aforementioned bifidobacteria growth promoter, wherein the bifidobacteria is Bifidobacterium longum.
In the present invention, the Bifidobacterium longum strain is the Bifidobacterium longum ATCC BAA-999 strain and / or the Bifidobacterium longum type strain ATCC15700 strain. An agent is provided.

 本発明の乳タンパク質分解物は、乳酸菌由来の細胞壁局在性タンパク質分解酵素PrtPにより乳タンパク質を加水分解することにより得られるものであるため、量産性に優れており、比較的安価に製造することも可能である。
 また、本発明のビフィズス菌増殖促進剤は、従来に無くビフィズス菌、特にビフィドバクテリウム・ロンガムを増殖させることができる。また、有効成分である乳タンパク質分解物は乳由来物質であるため、本発明のビフィズス菌増殖促進剤は、発酵乳等の乳由来原料でビフィズス菌を培養して製造される飲食品にも、乳タンパク質以外のタンパク質アレルギーに配慮する必要がなく使用することも可能であり、発酵乳等の乳製品の設計上有用である。
The milk protein degradation product of the present invention is obtained by hydrolyzing milk protein with a cell wall-localized proteolytic enzyme PrtP derived from lactic acid bacteria, so that it is excellent in mass productivity and manufactured at a relatively low cost. Is also possible.
Further, the bifidobacteria growth promoter of the present invention is unprecedented and can grow bifidobacteria, particularly Bifidobacterium longum. Moreover, since the milk protein degradation product which is an active ingredient is a milk-derived substance, the bifidobacteria growth promoter of the present invention is also applied to foods and drinks produced by culturing bifidobacteria with milk-derived raw materials such as fermented milk. It can be used without having to consider protein allergies other than milk protein, and is useful in designing dairy products such as fermented milk.

ラクトコッカス・ラクチスの各菌株由来のDNAを鋳型として、PrtP酵素遺伝子を検出するプライマーを用いてPCRを行った結果得られたPCR産物を、電気泳動法により分離し、染色により検出したバンドパターンを示した図である。Using the DNA derived from each strain of Lactococcus lactis as a template, the PCR product obtained as a result of PCR using the primer for detecting the PrtP enzyme gene was separated by electrophoresis, and the band pattern detected by staining was detected. FIG.

 本発明の乳タンパク質分解物は、細胞壁局在性タンパク質分解酵素PrtP(以下、単に「PrtP酵素」と記載することがある。)を有する乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画された前記酵素画分からなる群より選択される1以上を用いて、乳タンパク質を加水分解することにより得られることを特徴とする。本発明の乳タンパク質分解物は、ビフィズス菌増殖促進活性を有しているため、本発明の乳タンパク質分解物を有効成分とすることにより、ビフィズス菌増殖促進効果の高い優れたビフィズス菌増殖促進剤を得ることができる。本発明の乳タンパク質分解物がビフィズス菌増殖促効果を奏する理由は明らかではないが、乳タンパク質を、PrtPを用いて加水分解することにより、ビフィズス菌増殖促進作用を有するオリゴペプチドが得られるためではないかと推察される。 The milk protein degradation product of the present invention includes a living lactic acid bacterium having a cell wall-localized proteolytic enzyme PrtP (hereinafter sometimes simply referred to as “PrtP enzyme”), a crushed cell product of the lactic acid bacterium, and It is obtained by hydrolyzing milk protein using one or more selected from the group consisting of the enzyme fractions fractionated from the lactic acid bacteria. Since the milk protein degradation product of the present invention has a bifidobacteria growth promoting activity, an excellent bifidobacteria growth promoter having a high bifidobacteria growth promoting effect can be obtained by using the milk protein degradation product of the present invention as an active ingredient. Can be obtained. The reason why the milk protein degradation product of the present invention exerts the bifidobacteria growth-promoting effect is not clear. It is guessed that there is not.

 本発明において用いられる乳酸菌は、PrtP酵素を有している。PrtP酵素は、細胞膜に存在し、細胞表面に活性部位が剥き出しになっている酵素である。PrtP酵素を有している乳酸菌としては、例えば、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリス(Lactococcus lactis subsp.cremoris)やラクトコッカス・ラクチス・サブスピーシーズ・ラクチス(Lactococcus lactis subsp. lactis)等のラクトコッカス属菌において、PrtPを有する菌株が幾つか報告されている。 The lactic acid bacterium used in the present invention has a PrtP enzyme. The PrtP enzyme is an enzyme that exists in the cell membrane and has an active site exposed on the cell surface. Examples of lactic acid bacteria having a PrtP enzyme include Lactococcus lactis subspices cremoris and Lactococcus lactis subspice lactos. In the genus, several strains having PrtP have been reported.

 これまでに、ラクトコッカス・ラクチス由来のPrtP酵素には、P型(α―カゼインを余り分解せず、β―カゼインをC末端の近辺からよく分解する)、PIII型(α―カゼイン及びβ―カゼインをC末端及びN末端の両方からよく分解する)及びその中間型(P/PIII型)が知られている(例えば、Reid,JR.et al.、Applied and Environmental Microbiology、1994年、第60巻第3号、第801~806ページ参照。)。
 具体的には、ラクトコッカス・ラクチス由来のPrtP酵素として、NCBI(National center for Biotechnology Information)にアクセッション番号AY542690、AY542691等として遺伝子配列が登録されているPrtP酵素等が挙げられる。
To date, PrtP enzymes derived from Lactococcus lactis include P type I (which does not degrade α-casein very much and β-casein is degraded well from the vicinity of the C-terminal), type P III (α-casein and β-casein is well resolved from both C-terminus and N-terminus) and its intermediate form (P I / P III type) (eg, Reid, JR. et al., Applied and Environmental Microbiology, 1994). (See Years, Volume 60, Issue 3, pages 801-806.)
Specific examples of PrtP enzymes derived from Lactococcus lactis include PrtP enzymes whose gene sequences are registered in NCBI (National Center for Biotechnology Information) as accession numbers AY542690, AY5422691, and the like.

 ある乳酸菌が、PrtP酵素含有乳酸菌(PrtP酵素を有する乳酸菌)であるか否かは、例えば、PCR(Polymerase Chain Reaction)等の遺伝子解析技術を用いて、PrtP酵素をコードするPrtP遺伝子を有しているか否かを調べることにより確認することができる。 Whether or not a certain lactic acid bacterium is a PrtP enzyme-containing lactic acid bacterium (lactic acid bacterium having a PrtP enzyme) has, for example, a PrtP gene encoding a PrtP enzyme using a gene analysis technique such as PCR (Polymerase Chain Reaction). It can be confirmed by examining whether or not.

 PrtP酵素は、細胞外に酵素活性部位を有するため、培地中のタンパク質を分解することができる。例えば、乳酸菌が乳性培地で増殖するときに、PrtP酵素が、乳性培地中の乳タンパク質を分解し、乳酸菌の生育に必要となるオリゴペプチドやアミノ酸が提供される。このため、PrtP酵素を有するラクトコッカス・ラクチスは、10%(W/W)還元脱脂粉乳培地で、25~30℃の温度範囲で16時間培養した時に、培地を凝固させることができるほど増殖が早く、強い発酵性を有する、という特徴がある。このような増殖性や発酵性が高いという特徴を利用して、PrtP酵素含有乳酸菌を検出することもできる。その他、PrtP酵素活性を検出することによっても、PrtP酵素含有乳酸菌を検出することができる。 Since the PrtP enzyme has an enzyme active site outside the cell, it can degrade proteins in the medium. For example, when a lactic acid bacterium grows in a milky medium, the PrtP enzyme degrades milk protein in the milky medium, and oligopeptides and amino acids necessary for the growth of the lactic acid bacterium are provided. Therefore, Lactococcus lactis with PrtP enzyme grows so that the medium can be solidified when cultured in a 10% (W / W) reduced skim milk medium at a temperature range of 25-30 ° C. for 16 hours. It is fast and has strong fermentability. PrtP enzyme-containing lactic acid bacteria can also be detected by utilizing such characteristics of high growth and fermentability. In addition, PrtP enzyme-containing lactic acid bacteria can also be detected by detecting PrtP enzyme activity.

 本発明に用いられる乳酸菌は、PrtP酵素を有するものであれば特に限定されるものではないが、ラクトコッカス属菌であることが好ましく、ラクトコッカス・ラクチスであることがより好ましく、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスやラクトコッカス・ラクチス・サブスピーシーズ・ラクチス等であることがさらに好ましい。
 発酵乳等のビフィズス菌を原料とする乳製品において、従来から原料として使用されていることから、安全性が高いと考えられるためである。PrtP酵素を有するラクトコッカス・ラクチスとしては、例えば、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株や、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株等がある。
The lactic acid bacterium used in the present invention is not particularly limited as long as it has a PrtP enzyme, but is preferably a bacterium belonging to the genus Lactococcus, more preferably Lactococcus lactis, and Lactococcus lactis. -Subspecies Cremolis and Lactococcus lactis subspecies lactis are more preferable.
This is because dairy products made from bifidobacteria such as fermented milk have been used as raw materials and are considered to be highly safe. Examples of Lactococcus lactis having PrtP enzyme include Lactococcus lactis subspices cremolith NBRC100676 T strain, Lactococcus lactis subspices lactis JCM20101 strain and the like.

 本発明において、PrtP酵素含有乳酸菌の前培養に用いられる培地は、ラクトコッカス・ラクチスの培養に通常用いられる培地であれば、特に限定されるものではないが、Difco(登録商標) M17 Broth(Becton,Dickinson社製)等の市販の半合成培地や、還元脱脂粉乳培地等の乳性培地であることが好ましい。その他、前培養に用いられる培地には、グルコースや酵母エキス等の生育促進物質や、L-システイン等の還元剤等を添加することができる。また、前培養に用いられる培地は、殺菌処理をしたものを用いる。該殺菌処理は、通常用いられる方法で行うことができ、例えば、80~122℃で5~40分間、好ましくは85~95℃で5~35分間の加熱処理により行うことができる。 In the present invention, the medium used for the preculture of the PrtP enzyme-containing lactic acid bacteria is not particularly limited as long as it is a medium that is usually used for culturing Lactococcus lactis, but Difco (registered trademark) M17 Broth (Becton And a commercially available semi-synthetic medium such as Dickinson) or a dairy medium such as a reduced skim milk medium. In addition, growth promoting substances such as glucose and yeast extract, reducing agents such as L-cysteine, and the like can be added to the medium used for preculture. Moreover, the culture medium used for preculture uses what sterilized. The sterilization treatment can be performed by a commonly used method, for example, by heat treatment at 80 to 122 ° C. for 5 to 40 minutes, preferably 85 to 95 ° C. for 5 to 35 minutes.

 本発明において、乳タンパク質の加水分解に用いられるものとしては、PrtP酵素の酵素活性を維持しているものであれば、特に限定されるものではないが、PrtP酵素含有乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画されたPrtP酵素画分であることが好ましい。 In the present invention, the one used for the hydrolysis of milk protein is not particularly limited as long as the enzyme activity of the PrtP enzyme is maintained, but the live cell of the PrtP enzyme-containing lactic acid bacterium, It is preferable that it is the crushed cell body of lactic acid bacteria, and the PrtP enzyme fraction fractionated from the said lactic acid bacteria.

 本発明において用いられるPrtP酵素含有乳酸菌の生菌体は、常法により培養した乳酸菌をそのまま用いてもよく、凍結乾燥等の常法により調整した乾燥菌末であってもよい。培養した乳酸菌としては、培養に用いた培地ごと用いてもよく、遠心分離処理等により培地から菌体のみを回収した後、適当なバッファー等に懸濁させたものであってもよい。
 余分な培地等を除去し得ること、また濃縮や希釈により濃度を調整することも可能であることから、培地から回収した菌体をバッファーに懸濁させたものを用いることが好ましい。
The live cell of the PrtP enzyme-containing lactic acid bacterium used in the present invention may be a lactic acid bacterium cultured by a conventional method as it is, or may be a dry bacterium powder prepared by a conventional method such as lyophilization. The cultured lactic acid bacteria may be used together with the medium used for the culture, or may be one obtained by collecting only the cells from the medium by centrifugation or the like and then suspending them in an appropriate buffer or the like.
Since it is possible to remove excess medium and the concentration can be adjusted by concentration or dilution, it is preferable to use a suspension of cells recovered from the medium in a buffer.

 培地から回収した菌体を懸濁させるバッファー等としては、乳酸菌を生菌の状態で懸濁させることができる溶媒であれば、特に限定されるものではなく、乳酸菌等の懸濁に通常用いられるバッファー等を用いることができるが、カルシウムイオンを含むバッファー等であることが好ましい。懸濁に用いられるバッファーのpHとしては、4.5~8.0であることが好ましい。該バッファーとして、例えば、MESバッファー、HEPESバッファー、リン酸バッファー等が挙げられる。その他、生理食塩水であってもよい。 The buffer for suspending the cells recovered from the medium is not particularly limited as long as it is a solvent that can suspend lactic acid bacteria in a live state, and is usually used for suspending lactic acid bacteria. Although a buffer etc. can be used, it is preferable that it is a buffer containing calcium ion. The pH of the buffer used for the suspension is preferably 4.5 to 8.0. Examples of the buffer include MES buffer, HEPES buffer, and phosphate buffer. In addition, physiological saline may be used.

 本発明において用いられるPrtP酵素含有乳酸菌の菌体破砕物は、該乳酸菌をPrtP酵素の酵素活性を損なうことなく破砕することにより得られたものであれば、特に限定されるものではない。このような破砕方法として、例えば、超音波を利用した破砕処理、ガラスビーズ破砕処理、浸透圧ショックを利用した破砕処理等が挙げられる。なお、これらの破砕処理は、50℃以下、好ましくは室温以下、より好ましくは10℃以下の低温下において行うことが好ましい。加熱により、PrtP酵素が失活してしまうためである。 The cell disruption product of the PrtP enzyme-containing lactic acid bacterium used in the present invention is not particularly limited as long as it is obtained by crushing the lactic acid bacterium without impairing the enzyme activity of the PrtP enzyme. Examples of such a crushing method include a crushing process using ultrasonic waves, a glass bead crushing process, and a crushing process using osmotic shock. These crushing treatments are preferably performed at a low temperature of 50 ° C. or lower, preferably room temperature or lower, more preferably 10 ° C. or lower. This is because the PrtP enzyme is deactivated by heating.

 本発明において用いられるPrtP酵素含有乳酸菌から分画されたPrtP酵素画分は、該乳酸菌から、PrtP酵素の酵素活性を損なうことなく、PrtP酵素を分画することにより得られたものであれば、特に限定されるものではない。例えば、培養後に培地から回収された乳酸菌を、バッファー中に懸濁して保持した後、遠心分離処理等によって菌体を除去することにより、乳酸菌の細胞表面から遊離したPrtP酵素を含む上清を、PrtP酵素画分として得ることができる。該バッファーに、EDTA等のキレート剤を添加することにより、乳酸菌の細胞表面からPrtP酵素が遊離されやすくなるため、EDTA等のキレート剤を添加したバッファーを用いることが好ましい。このような上清を得るためのバッファーとしては、例えば、上記生菌体の懸濁に用いることができるバッファーとして挙げられたものに、EDTA等のキレート剤を添加したものを用いることができる。また、バッファー中に乳酸菌を保持する温度は、50℃未満であれば特に限定されるものではないが、4~37℃程度であることが好ましく、30℃程度であることがより好ましい。また、保持時間は、保持温度やバッファーの種類等を考慮して適宜決定することができるが、1時間以内であることが好ましく、5~30分間であることがより好ましく、5~15分間であることがさらに好ましい。 If the PrtP enzyme fraction fractionated from the PrtP enzyme-containing lactic acid bacterium used in the present invention is obtained by fractionating the PrtP enzyme from the lactic acid bacterium without impairing the enzyme activity of the PrtP enzyme, It is not particularly limited. For example, after culturing the lactic acid bacteria collected from the culture medium after suspending in a buffer, removing the bacterial cells by centrifugation or the like, the supernatant containing the PrtP enzyme released from the cell surface of the lactic acid bacteria, It can be obtained as a PrtP enzyme fraction. The addition of a chelating agent such as EDTA to the buffer facilitates the release of the PrtP enzyme from the cell surface of lactic acid bacteria. Therefore, it is preferable to use a buffer to which a chelating agent such as EDTA is added. As a buffer for obtaining such a supernatant, for example, a buffer obtained by adding a chelating agent such as EDTA to the above-mentioned buffers that can be used for suspending viable cells can be used. The temperature at which lactic acid bacteria are retained in the buffer is not particularly limited as long as it is less than 50 ° C., but is preferably about 4 to 37 ° C., more preferably about 30 ° C. The holding time can be appropriately determined in consideration of the holding temperature, the type of buffer, etc., but is preferably within 1 hour, more preferably 5 to 30 minutes, and 5 to 15 minutes. More preferably it is.

 なお、このようにして得られた上清を、透析処理することにより、PrtP酵素画分からキレート剤を除去することができる。さらに、分画されたPrtP酵素画分は、凍結濃縮等の公知の手法により、PrtP酵素活性を損なうことなく濃縮することもできる。その他、乳酸菌の菌体破砕物を、硫酸アンモニウム沈殿法やクロマトグラフィー法等の公知の分画手段を用いて分画することにより得られたPrtP酵素画分であってもよい。 Note that the chelating agent can be removed from the PrtP enzyme fraction by dialysis of the supernatant thus obtained. Furthermore, the fractionated PrtP enzyme fraction can be concentrated by a known technique such as freeze concentration without impairing the PrtP enzyme activity. In addition, it may be a PrtP enzyme fraction obtained by fractionating a crushed bacterial body of lactic acid bacteria using a known fractionation means such as ammonium sulfate precipitation method or chromatography method.

 本発明において用いられる乳タンパク質は、ウシ、ヤギ、ウマ、ヒツジ等の動物(但しヒトを除く)から採取された乳由来のタンパク質であれば、特に限定されるものではなく、食用に通常用いられる乳由来のタンパク質を適宜選択して用いることができる。本発明においては、産業上の利用価値の高い牛乳に含まれている乳タンパク質であることが好ましい。
 また、牛乳タンパク質としては、カゼインであってもよく、ホエータンパク質(ホエー中に含まれるタンパク質)であってもよく、トータルミルクプロテインであってもよい。
 本発明において用いられる乳タンパク質としては、牛乳由来のカゼイン又はトータルミルクプロテインであることが好ましく、牛乳由来のカゼインであることがより好ましい。よりビフィズス菌増殖促進効果が高い乳タンパク質分解物を得ることができるためである。
 なお、カゼイン、トータルミルクプロテイン、ホエータンパク質等の乳タンパク質は、常法により調製したものを用いることができる。また、市販されているものを用いてもよい。
The milk protein used in the present invention is not particularly limited as long as it is a milk-derived protein collected from animals such as cows, goats, horses and sheep (excluding humans), and is usually used for food. Milk-derived protein can be appropriately selected and used. In this invention, it is preferable that it is the milk protein contained in the milk with high industrial utility value.
The milk protein may be casein, whey protein (protein contained in whey), or total milk protein.
The milk protein used in the present invention is preferably casein derived from milk or total milk protein, and more preferably casein derived from milk. This is because a milk protein degradation product having a higher bifidobacteria growth promoting effect can be obtained.
In addition, as for milk proteins such as casein, total milk protein, and whey protein, those prepared by a conventional method can be used. Moreover, you may use what is marketed.

 本発明の乳タンパク質分解物は、乳タンパク質に、PrtP酵素含有乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画されたPrtP酵素画分からなる群より選択される1以上を添加して加水分解することにより得られる。添加されるPrtP酵素含有乳酸菌の生菌体、菌体破砕物、及びPrtP酵素画分は、上記のように調整したものを、適宜に凍結濃縮または凍結乾燥したものとして添加することが好ましい。また、この加水分解の反応条件は、PrtP酵素により酵素反応が可能な条件であれば特に限定されるものではなく、PrtP酵素の種類、乳タンパク質の種類等を考慮して、適宜決定することができる。例えば、由来する乳酸菌が生育(増殖)し得る環境と実質的に同等の条件であれば、PrtP酵素が酵素活性を有することが期待できる。 The milk protein degradation product of the present invention is one or more selected from the group consisting of a milk protein, a living cell of a PrtP enzyme-containing lactic acid bacterium, a crushed cell of the lactic acid bacterium, and a PrtP enzyme fraction fractionated from the lactic acid bacterium. It is obtained by adding and hydrolyzing. The added PrtP enzyme-containing lactic acid bacteria live cells, crushed cell bodies, and PrtP enzyme fractions are preferably added as prepared by appropriately freeze-concentrating or lyophilizing those prepared as described above. The hydrolysis reaction conditions are not particularly limited as long as the enzymatic reaction can be performed by the PrtP enzyme, and may be appropriately determined in consideration of the type of PrtP enzyme, the type of milk protein, and the like. it can. For example, the PrtP enzyme can be expected to have enzyme activity under conditions that are substantially equivalent to the environment in which the derived lactic acid bacteria can grow (proliferate).

 本発明においては、加水分解における反応温度は、50℃未満であることが好ましく、10~42℃であることがより好ましく、20~37℃であることがさらに好ましく、30℃前後であることが特に好ましい。
 また、加水分解に供される乳タンパク質は、pH6.0~8.0に調整されたものであることが好ましく、6.0~7.5に調整されたものであることがより好ましく、6.5前後に調整されたものであることがさらに好ましい。基質である乳タンパク質のpHが6.0以上である場合には、得られた乳タンパク質分解物を加熱殺菌する場合に、タンパク質凝集が生じ難い。一方、乳タンパク質のpHが8.0以下である場合には、得られた乳タンパク質分解物を加熱殺菌する場合に、タンパク質の変性が生じ難い。
In the present invention, the reaction temperature in the hydrolysis is preferably less than 50 ° C., more preferably 10 to 42 ° C., further preferably 20 to 37 ° C., and about 30 ° C. Particularly preferred.
The milk protein to be subjected to hydrolysis is preferably adjusted to pH 6.0 to 8.0, more preferably adjusted to 6.0 to 7.5. More preferably, it is adjusted to around 5. When the pH of the milk protein that is the substrate is 6.0 or more, protein aggregation hardly occurs when the obtained milk protein degradation product is heat-sterilized. On the other hand, when the pH of milk protein is 8.0 or less, protein denaturation hardly occurs when the obtained milk protein degradation product is heat sterilized.

 本発明においては、加水分解における反応系中の乳タンパク質濃度は、所望の乳タンパク質分解物の濃度や、添加するPrtP酵素の量、反応時間等を考慮して適宜決定することができる。本発明においては、加水分解における乳タンパク質濃度は、0.5重量%以上であることが好ましく、1重量%以上であることがより好ましい。よりビフィズス菌増殖促進能に優れた乳タンパク質分解物を得ることができるためである。 In the present invention, the milk protein concentration in the reaction system in the hydrolysis can be appropriately determined in consideration of the desired milk protein degradation product concentration, the amount of PrtP enzyme to be added, the reaction time, and the like. In the present invention, the milk protein concentration in the hydrolysis is preferably 0.5% by weight or more, and more preferably 1% by weight or more. This is because a milk protein degradation product with more excellent bifidobacteria growth promoting ability can be obtained.

 また、本発明においては、加水分解における反応系中に添加されるPrtP酵素含有乳酸菌の生菌体、菌体破砕物、及びPrtP酵素画分の量は、添加する乳タンパク質量等を考慮して適宜決定することができるが、後述するPrtP酵素活性の単位として、1Unit/ml以上となるように添加することが好ましい。加水分解の反応時間は、反応温度、乳タンパク質濃度、添加するPrtP酵素の量等を考慮して適宜決定することができるが、例えば、PrtP酵素含有乳酸菌の生菌体等の添加量が後述するPrtP酵素活性の単位として3.5Unit/mlであり、反応温度が30℃である場合には、5時間以上であることが好ましい。 Further, in the present invention, the amount of the PrtP enzyme-containing lactic acid bacterium live cells, crushed cells, and PrtP enzyme fraction added to the reaction system in the hydrolysis is determined in consideration of the amount of milk protein to be added and the like. Although it can determine suitably, it is preferable to add so that it may become 1 Unit / ml or more as a unit of the PrtP enzyme activity mentioned later. The hydrolysis reaction time can be appropriately determined in consideration of the reaction temperature, milk protein concentration, the amount of PrtP enzyme to be added, and the like. For example, the addition amount of live cells of PrtP enzyme-containing lactic acid bacteria will be described later. When the unit of PrtP enzyme activity is 3.5 Unit / ml and the reaction temperature is 30 ° C., it is preferably 5 hours or longer.

 なお、本発明においては、加水分解により得られた乳タンパク質分解物は、反応後の反応液をそのまま用いてもよいが、反応後に加熱処理等により反応液中のPrtP酵素を失活させておくことが好ましい。 In the present invention, the milk protein degradation product obtained by hydrolysis may use the reaction solution after the reaction as it is, but after the reaction, the PrtP enzyme in the reaction solution is inactivated by heat treatment or the like. It is preferable.

 本発明のビフィズス菌増殖促進剤は、上記のように製造された乳タンパク質分解物を有効成分とする。このように、乳由来成分を有効成分とするため、発酵乳等の乳由来原料でビフィズス菌を培養して製造される飲食品に対して、乳タンパク質以外のタンパク質アレルギーに配慮することなく用いることができる。 The bifidobacteria growth promoter of the present invention contains the milk protein degradation product produced as described above as an active ingredient. Thus, in order to use milk-derived ingredients as active ingredients, food and drink produced by culturing bifidobacteria with milk-derived raw materials such as fermented milk should be used without considering protein allergies other than milk proteins. Can do.

 本発明のビフィズス菌増殖促進剤中に含まれる本発明の乳タンパク質分解物量は、ビフィズス菌増殖促進効果が得られる量であれば特に限定されるものではないが、10重量%以上であることが好ましく、15重量%以上であることがより好ましく、20重量%以上であることがさらに好ましく、40重量%以上であることが特に好ましい。 The amount of the milk protein degradation product of the present invention contained in the bifidobacteria growth promoter of the present invention is not particularly limited as long as the bifidobacteria growth promoting effect is obtained, but it may be 10% by weight or more. It is preferably 15% by weight or more, more preferably 20% by weight or more, and particularly preferably 40% by weight or more.

 本発明のビフィズス菌増殖促進剤の剤型は特に限定されるものではなく、凍結乾燥品等の粉末剤であってもよく、錠剤であってもよく、液剤であってもよく、ペースト状であってもよい。また、本発明のビフィズス菌増殖促進剤は、本発明の乳タンパク質分解物によるビフィズス菌増殖促進効果を阻害しない限り、その他の成分を含有していてもよい。その他の成分として、例えば、澱粉や乳糖等の、一般的に添加される剤型補助剤や安定化剤等が挙げられる。その他、本発明の乳タンパク質分解物の他に、ビフィズス菌増殖促進作用を有する公知物質を添加してもよい。 The dosage form of the Bifidobacterium growth promoter of the present invention is not particularly limited, and may be a powder such as a lyophilized product, a tablet, a liquid, or a paste. There may be. Moreover, the bifidobacteria growth promoter of this invention may contain the other component, unless the bifidobacteria growth promotion effect by the milk protein degradation product of this invention is inhibited. Examples of other components include commonly added adjuvants and stabilizers such as starch and lactose. In addition to the milk protein degradation product of the present invention, a known substance having a bifidobacteria growth promoting action may be added.

 本発明のビフィズス菌増殖促進剤は、具体的には、ビフィズス菌の培養培地に添加することにより、ビフィズス菌増殖促進効果を発揮することができる。培養培地に添加する量は、ビフィズス菌増殖促進効果が得られる量であれば特に限定されるものではなく、ビフィズス菌増殖促進剤中の乳タンパク質分解物量、ビフィズス菌の培養培地の組成、スターターであるビフィズス菌の接種量、ビフィズス菌の種類等を考慮して、適宜決定することができる。本発明のビフィズス菌増殖促進剤としては、例えば、ビフィズス菌の培養培地に対して、0.01~10(V/V)%となるように添加することが好ましく、0.1~5(V/V)%となるように添加することが特に好ましい。 Specifically, the bifidobacteria growth promoter of the present invention can exert a bifidobacteria growth promoting effect by adding it to a culture medium of bifidobacteria. The amount to be added to the culture medium is not particularly limited as long as the effect of promoting the growth of bifidobacteria is obtained. The amount of milk protein degradation product in the bifidobacteria growth promoter, the composition of the culture medium of bifidobacteria, and the starter It can be determined as appropriate in consideration of the inoculation amount of a certain bifidobacteria, the type of bifidobacteria and the like. The bifidobacteria growth promoter of the present invention is preferably added so as to be 0.01 to 10 (V / V)%, for example, 0.1 to 5 (V / V)% is particularly preferable.

 本発明のビフィズス菌増殖促進剤が添加されるビフィズス菌の培養培地としては、通常用いられる培地であれば、特に限定されるものではなく、所望のビフィズス菌含有製品の種類等を考慮して適宜選択することができる。例えば、ビフィズス菌発酵乳を製造するために用いられる発酵用ベースとしては、発酵乳の製造に通常用いられるベースであれば、特に限定されるものではない。該ベースは、例えば、牛乳、脱脂乳、生クリーム、バター、全粉乳、脱脂粉乳等に、必要に応じて蔗糖等の甘味料、ペクチン、果実、フルーツジュース、寒天、ゼラチン、油脂、香料、着色料、安定剤、還元剤等を配合し、常法に従って殺菌、均質化、冷却等することにより調製することができる。 The culture medium for bifidobacteria to which the agent for promoting growth of bifidobacteria of the present invention is added is not particularly limited as long as it is a commonly used medium. You can choose. For example, the fermenting base used for producing bifidobacteria fermented milk is not particularly limited as long as it is a base usually used for producing fermented milk. The base is, for example, milk, skim milk, fresh cream, butter, whole milk powder, skim milk powder, sweeteners such as sucrose, pectin, fruit, fruit juice, agar, gelatin, oil, fat, flavor, coloring It can be prepared by blending a material, a stabilizer, a reducing agent, etc., and sterilizing, homogenizing, cooling and the like according to a conventional method.

 なお、本発明のビフィズス菌増殖促進剤が添加されるビフィズス菌は、常法により前培養したものを用いることができる。ビフィズスの前培養に用いられる培養培地は、通常用いられる培地であれば、特に限定されるものではないが、乳性培地であることが好ましい。取り扱いが簡便であるため、還元脱脂粉乳培地が特に好ましい。該還元脱脂粉乳培地の濃度は、3%(W/W)以上が好ましく、8%(W/W)以上が特に好ましい。その他、前培養に用いられる培地には、酵母エキス等の生育促進物質や、L-システイン等の還元剤等を添加することができる。特にビフィズス菌は乳性培地での増殖性が低いため、生育促進物質を添加した培地を用いることが好ましい。例えば、0.1~1%(W/W)の酵母エキスを含有した培地を用いることができる。また、前培養に用いられる培地は、殺菌処理をしたものを用いる。該殺菌処理は、通常用いられる方法で行うことができ、例えば、80~122℃で5~40分間、好ましくは85~95℃で5~35分間の加熱処理により行うことができる。 The bifidobacteria to which the bifidobacteria growth promoter of the present invention is added can be those pre-cultured by a conventional method. The culture medium used for pre-culture of bifido is not particularly limited as long as it is a commonly used medium, but is preferably a milky medium. A reduced skim milk medium is particularly preferred because of easy handling. The concentration of the reduced skim milk medium is preferably 3% (W / W) or more, particularly preferably 8% (W / W) or more. In addition, growth-promoting substances such as yeast extract, reducing agents such as L-cysteine, and the like can be added to the medium used for preculture. In particular, since bifidobacteria have a low growth ability in a milky medium, it is preferable to use a medium to which a growth promoting substance is added. For example, a medium containing 0.1 to 1% (W / W) yeast extract can be used. Moreover, the culture medium used for preculture uses what sterilized. The sterilization treatment can be performed by a commonly used method, for example, by heat treatment at 80 to 122 ° C. for 5 to 40 minutes, preferably 85 to 95 ° C. for 5 to 35 minutes.

 本発明のビフィズス菌増殖促進剤の増殖対象菌は、ビフィズス菌であれば特に限定されるものではないが、ビフィドバクテリウム・ロンガムであることが好ましい。本発明の乳タンパク質分解物による増殖促進効果が、より顕著に得られるためである。特に、ビフィドバクテリウム・ロンガムATCC BAA-999株や、ビフィドバクテリウム・ロンガム タイプストレインATCC15700株であることが好ましい。 The growth target bacterium of the Bifidobacterium growth promoter of the present invention is not particularly limited as long as it is a Bifidobacterium, but is preferably Bifidobacterium longum. This is because the growth promoting effect of the milk protein degradation product of the present invention can be obtained more significantly. In particular, Bifidobacterium longum ATCC BAA-999 strain and Bifidobacterium longum type strain ATCC15700 strain are preferable.

 また、本発明のビフィズス菌増殖促進剤は、従来に無くビフィズス菌、特にビフィドバクテリウム・ロンガムを増殖させることができるため、本発明のビフィズス菌増殖促進剤を用いることにより、より整腸効果が高く、健康管理上も有用な、ビフィズス菌発酵乳等のビフィズス菌含有飲食品を製造することができる。 Further, since the bifidobacteria growth promoter of the present invention is capable of growing bifidobacteria, particularly Bifidobacterium longum, which has never existed before, the use of the bifidobacteria growth promoter of the present invention makes it more effective in regulating the intestine. It is possible to produce foods and beverages containing bifidobacteria such as bifidobacteria fermented milk, which are high in health and useful for health care.

 以下、本発明の乳タンパク質分解物の製造方法及びビフィズス菌増殖促進作用について、さらに詳細に説明する。
1.ラクトコッカス・ラクチスの菌株のPrtP酵素保有性の検出
 ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676(ATCC19257)株、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスATCC-9625株、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスNBRC12007(NCDO 497)株、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株、及びラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20128株が、PrtP酵素を保有しているか否かを確認した。
 具体的には、ラクトース及びグルコースを0.5%添加したDifco(登録商標) M17 Broth(Becton,Dickinson社製)に、各菌株を3%接種し、30℃で16時間培養した。遠心分離により菌体を得、DNeasy Blood and Tissue kit(QIAGEN社製)を用いてDNAを抽出し、PCR法によりPrtP遺伝子の保有性を確認した。PCRは参考文献(Journal of Appieid Microbiology、2006年、第100巻、第1307~1317ページ。)に記載の手法に準じて行った。プライマーは、フォワードプライマーGBf(GCAAATACGGTGACGGCTGCGA)及びリバースプライマーGB2r(TGAGCATTATAATAGGTCTTCTTCC)のプライマーセット、もしくはフォワードプライマーGHf(CAAATACGGTGACGGCTGCTAA)及びリバースプライマーGH2r(TAGCATTATAATAGGTCTTCGTCA)のプライマーセットを用いた。
Hereinafter, the production method of the milk protein degradation product and the bifidobacteria growth promoting action of the present invention will be described in more detail.
1. Detection of PrtP enzyme retention in strains of Lactococcus lactis Lactococcus lactis subspecies Cremolis NBRC100676 T (ATCC19257 T ) strain, Lactococcus lactis subspices cremolith ATCC-9625 strain, Lactococcus lactis subs It was confirmed whether Spices lactis NBRC12007 (NCDO 497) strain, Lactococcus lactis subspices lactis JCM20101 strain, and Lactococcus lactis subspices lactis JCM20128 strain possessed PrtP enzyme.
Specifically, 3% of each strain was inoculated into Difco (registered trademark) M17 Broth (Becton, manufactured by Dickinson) supplemented with 0.5% lactose and glucose, and cultured at 30 ° C. for 16 hours. Bacteria were obtained by centrifugation, DNA was extracted using DNeasy Blood and Tissue kit (manufactured by QIAGEN), and the possession of the PrtP gene was confirmed by PCR. PCR was performed according to the method described in the reference (Journal of Applied Microbiology, 2006, Vol. 100, pp. 1307-1317). The primer used was a primer set of forward primer GBf (GCAAATACGGTGACGGCTGGCGA) and reverse primer GB2r (TGAGCATTATAATAGGTCTTTCTTCC), or forward primer GHf (CAAATACGGTGACGCGCTGCTAAA) and reverse primer GH2r (TAGCATTATATAGTGTG).

 図1はPCR産物を電気泳動法により分離し、染色により検出したバンドパターンを示した図である。図1中、「1」は分子量マーカーを流したレーンであり、「2」はラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のPCR産物、「3」はラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株のPCR産物、「4」はラクトコッカス・ラクチス・サブスピーシーズ・ラクチスNBRC12007株のPCR産物、「5」はラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20128株のPCR産物、「6」はラクトコッカス・ラクチス・サブスピーシーズ・クレモリスATCC-9625株のPCR産物を、それぞれ流したレーンである。この結果、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株及びラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株にはPrtP遺伝子の保有が確認された。一方、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスATCC-9625株、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスNBRC12007株及びラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20128株では、のそれぞれの菌株には保有していないことが判明した。 FIG. 1 is a diagram showing band patterns obtained by separating PCR products by electrophoresis and detecting them by staining. In FIG. 1, “1” is a lane in which a molecular weight marker is passed, “2” is a PCR product of Lactococcus lactis subspecies Cremolis NBRC100676 T strain, and “3” is Lactococcus lactis subspices lactis. PCR product of JCM20101 strain, “4” is a PCR product of Lactococcus lactis subspecies lactis NBRC 12007 strain, “5” is a PCR product of Lactococcus lactis subspecies lactis JCM20128 strain, “6” is a lactococcus -Lanes in which PCR products of Lactis subspecies Cremolis ATCC-9625 strain were respectively flowed. As a result, it was confirmed that Lactococcus lactis sub-species Cremolis NBRC100676 T strain and Lactococcus lactis sub-species lactis JCM20101 strain possessed the PrtP gene. On the other hand, Lactococcus lactis subspecies Cremolis ATCC-9625 strain, Lactococcus lactis subspices lactis NBRC12007 strain and Lactococcus lactis subspices lactis JCM20128 strain each possesses Not found out.

2.PrtP酵素活性の単位定義
 まず、0.02%のFTC-カゼインを含む30mM MES-NaOH バッファー(pH6.5)0.4mlに、0.1mlの市販タンパク分解酵素トリプシン溶液(Sigma社製、酵素活性11,100Unit/mg)を添加し、30℃で1時間反応させた。5%のトリクロロ酢酸1.2mlを添加し、ボルテックスで混合後、室温にて15分静置した。15000×g、5分の遠心分離した上清液0.3mlを500mM Tris-HCl(pH8.5)2mlに混合し、蛍光強度を測定した。測定はMTP-800AFC/Labマイクロプレートリーダ(コロナ電気株式会社製)を用い、励起波長490nm、蛍光波長530nmの条件で行った。
 一方、前記トリプシン溶液の代わりに、後述の方法で調製したPrtP酵素遺伝子を有するラクトコッカス・ラクチスの生菌体、菌体破砕物又はPrtP酵素画分を添加し、同様に分解反応を行った。その結果、上記1ユニットのトリプシンの分解により得られた蛍光強度の値を、PrtP酵素遺伝子を有するラクトコッカス・ラクチスの生菌体、菌体破砕物又はPrtP酵素画分で分解した場合のPrtP酵素活性の1酵素単位と定義した。
2. Unit Definition of PrtP Enzyme Activity First, 0.4 ml of 30 mM MES-NaOH buffer (pH 6.5) containing 0.02% FTC-casein was added to 0.1 ml of a commercial proteolytic enzyme trypsin solution (manufactured by Sigma, enzyme activity). 11,100 Unit / mg) was added and reacted at 30 ° C. for 1 hour. 1.2 ml of 5% trichloroacetic acid was added, mixed by vortexing, and allowed to stand at room temperature for 15 minutes. 0.3 ml of the supernatant obtained by centrifugation at 15000 × g for 5 minutes was mixed with 2 ml of 500 mM Tris-HCl (pH 8.5), and the fluorescence intensity was measured. The measurement was performed using an MTP-800AFC / Lab microplate reader (Corona Electric Co., Ltd.) under conditions of an excitation wavelength of 490 nm and a fluorescence wavelength of 530 nm.
On the other hand, instead of the trypsin solution, a living cell body of Lactococcus lactis having a PrtP enzyme gene prepared by the method described later, a crushed cell body product, or a PrtP enzyme fraction was added, and a decomposition reaction was performed in the same manner. As a result, the fluorescence intensity value obtained by decomposing one unit of trypsin was converted into a PrtP enzyme in the case of degrading with a live cell of Lactococcus lactis having a PrtP enzyme gene, a crushed cell or a PrtP enzyme fraction. One enzyme unit of activity was defined.

3.乳タンパク質分解物の調製
 まず、70mMのβ―グリセロリン酸2ナトリウムを含む10%(W/W)還元脱脂粉乳を含む乳性培地を、95℃で30分間殺菌し、前記各菌株のシードカルチャーを3%接種し、30℃で16時間培養した。この際、菌株の必要に応じて、培地中に0.5%のグルコース及び0.05%の酵母エキスを添加した。その後、1%のクエン酸3ナトリウムと水酸化ナトリウム水溶液を用いてpH6.8に調整した後、遠心分離により菌体を得た。次に、菌体を10mM塩化カルシウム含有30mM MES-NaOH バッファー(pH6.5)で2回洗浄後、同bufferで懸濁し、10倍濃縮した洗浄菌体(生菌体)を得た。また、菌体の一部に対して、90℃で10分の加熱処理を行った。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液に生菌体又は加熱処理菌体を1%添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の過熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した溶液は、水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により50分の1容量まで濃縮した。
3. Preparation of milk protein degradation product First, a dairy medium containing 10% (W / W) reduced skim milk powder containing 70 mM disodium β-glycerophosphate was sterilized at 95 ° C. for 30 minutes, and the seed culture of each strain was determined. Inoculated with 3% and cultured at 30 ° C. for 16 hours. At this time, 0.5% glucose and 0.05% yeast extract were added to the medium as required by the strain. Thereafter, the pH was adjusted to 6.8 using 1% trisodium citrate and an aqueous sodium hydroxide solution, and the cells were obtained by centrifugation. Next, the cells were washed twice with 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM calcium chloride, suspended in the same buffer, and washed cells (live cells) concentrated 10 times. Moreover, the heat processing for 10 minutes were performed at 90 degreeC with respect to a part of microbial cell.
Next, 1% of viable cells or heat-treated cells was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and the mixture was maintained at 30 ° C. for 24 hours with gentle stirring. After the reaction, it was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected solution was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/50 volume by freeze concentration.

4.ビフィズス菌増殖促進活性の測定4-1 ビフィズス菌数の測定
 トータルミルクプロテイン5%(W/W)、乳糖5%(W/W)を含む培地を90℃で10分間殺菌し、前記のように調製したラクトコッカス・ラクチスの各菌株の菌体によるカゼイン分解物を一定量添加し、ビフィドバクテリウム・ロンガムATCC BAA-999株のカルチャー0.1%を接種し、37℃で16時間培養した。培養後に、TOSプロピオン酸寒天培地(ヤクルト薬品工業社製)を用いて、段階希釈法によりビフィズス菌数を測定した。
4). Measurement of bifidobacteria growth-promoting activity 4-1 Measurement of the number of bifidobacteria The medium containing total milk protein 5% (W / W) and lactose 5% (W / W) was sterilized at 90 ° C. for 10 minutes, as described above. A fixed amount of casein degradation product of each prepared strain of Lactococcus lactis was added, inoculated with 0.1% culture of Bifidobacterium longum ATCC BAA-999 strain, and cultured at 37 ° C. for 16 hours. . After cultivation, the number of bifidobacteria was measured by a serial dilution method using a TOS propionic acid agar medium (manufactured by Yakult Pharmaceutical Co., Ltd.).

4-2 pH変動の測定
 上記4-1の培養試験にて、ビフィズス菌の増殖に伴い、乳酸や酢酸を生成し、培地のpHを低下させることが知られている。このため、培地のpHの低下程度から、ビフィズス菌の増殖程度を判定することが出来る。pHの測定はpHメーター(HORIBA社製)を用いて行った。なお、本発明の乳タンパク分解物によるビフィズス菌増殖促進活性は無添加の対照と比較して、pH低下の違いが0.3以上を基準に判断した。
4-2 Measurement of pH Fluctuation In the culture test of 4-1, it is known that lactic acid and acetic acid are produced with the growth of bifidobacteria and the pH of the medium is lowered. For this reason, the degree of growth of bifidobacteria can be determined from the degree of decrease in the pH of the medium. The pH was measured using a pH meter (manufactured by HORIBA). The bifidobacteria growth-promoting activity of the milk protein degradation product of the present invention was judged based on a difference in pH decrease of 0.3 or more compared to the control without addition.

5.乳タンパク質分解物によるビフィズス菌への増殖促進作用
 まず、後記実施例1記載の通り、ビフィドバクテリウム・ロンガムATCC BAA-999株のカルチャーを調製した。
 次に、トータルミルクプロテイン5%(W/W)、乳糖5%(W/W)を含む培地を90℃で10分間殺菌し、前記のように調製したラクトコッカス・ラクチスの各菌株の菌体によるカゼイン分解物を1%と、ビフィドバクテリウム・ロンガムATCC BAA-999株のカルチャー0.1%を接種し、37℃で16時間培養した。該培養液を急冷し、ビフィズス菌数及びpHを測定した。測定結果を表1に示す。
5). First, a culture of Bifidobacterium longum ATCC BAA-999 strain was prepared as described in Example 1 below.
Next, a medium containing 5% (W / W) total milk protein and 5% (W / W) lactose was sterilized at 90 ° C. for 10 minutes, and the bacterial cells of each strain of Lactococcus lactis prepared as described above. 1% of the casein degradation product and 0.1% culture of Bifidobacterium longum ATCC BAA-999 strain were inoculated and cultured at 37 ° C. for 16 hours. The culture was rapidly cooled, and the number of bifidobacteria and pH were measured. The measurement results are shown in Table 1.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

 無添加対照と比べて、PrtP酵素遺伝子を有するラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株及びラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の生菌体によるカゼイン分解物添加では、pHが5.0以下まで低下し、ビフィズス菌数が3×10CFU/g前後に達した。対して、PrtP酵素遺伝子を有しないラクトコッカス・ラクチス・サブスピーシーズ・クレモリスATCC-9625株、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスNBRC12007株、及びラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20128株のそれぞれの生菌体によるカゼイン分解物添加では、pHが5.5以上であり、ビフィズス菌数が5×107CFU/g以下で、菌体無処理の対照と大きく違わなかった。一方、加熱処理菌体によるカゼイン分解物ではビフィズス菌増殖促進活性が見られなかった。
 すなわち、PrtP酵素遺伝子を有するラクトコッカス・ラクチスの生菌株による乳タンパク質分解物は、ビフィズス菌に対する増殖促進性を有していることが明らかである。
 なお、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株のカゼイン分解物に、より強いビフィズス菌増殖促進活性が見られたことから、以下、JCM20101株を用いて分解条件の検討を行った。
Compared with the additive-free control, the casein degradation product of the Lactococcus lactis subspices cremolith NBRC100676 strain and the Lactococcus lactis subspices lactis JCM20101 strain having the PrtP enzyme gene has a pH of 5. The number decreased to 0 or less, and the number of bifidobacteria reached around 3 × 10 8 CFU / g. In contrast, each of Lactococcus lactis subspecies Cremolis ATCC-9625 strain, Lactococcus lactis subspices lactis NBRC12007 strain, and Lactococcus lactis subspices lactis strain JCM20128 not having a PrtP enzyme gene When the casein degradation product was added by viable cells, the pH was 5.5 or more and the number of bifidobacteria was 5 × 10 7 CFU / g or less, which was not significantly different from the non-treated control. On the other hand, the casein degradation product by heat-treated cells did not show the bifidobacteria growth promoting activity.
That is, it is clear that the milk protein degradation product by the living strain of Lactococcus lactis having the PrtP enzyme gene has growth promoting ability against Bifidobacteria.
Since the casein degradation product of Lactococcus lactis subspecies lactis JCM20101 strain showed stronger bifidobacteria growth promoting activity, the degradation conditions were examined using the JCM20101 strain.

6.他の市販酵素との比較
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体(PrtP酵素含有生菌体)を得た。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液にPrtP酵素含有生菌体を、PrtP酵素単位として3.5Units/ml添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 一方、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液に上記生菌体の変わりに、市販タンパク分解酵素トリプシン(Sigma社製)を3.5Units/ml添加し、同様に分解を行った。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。結果を表2に示す。市販タンパク分解酵素トリプシンと比較して、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の生菌体によるカゼイン分解物は、強いビフィズス菌増殖促進活性を示した。
6). Comparison with Other Commercial Enzymes As described in 3 above, washed cells (PrtP enzyme-containing living cells) of Lactococcus lactis subspecies lactis JCM20101 strain were obtained.
Next, 3.5 unit / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and gently stirred at 30 ° C. for 24 hours. Retained. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
On the other hand, instead of the above living cells, a commercial proteolytic enzyme trypsin (manufactured by Sigma) was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein at a rate of 3.5 Units / ml. went. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 2. Compared with the commercially available proteolytic enzyme trypsin, the casein degradation product of the living cells of Lactococcus lactis subspecies lactis JCM20101 strain showed strong bifidobacteria growth promoting activity.

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

7.乳タンパク質の分解時間の影響
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体(PrtP酵素含有生菌体)を得た。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液にPrtP酵素含有生菌体を、PrtP酵素単位として3.5Units/ml添加し、緩やかに撹拌しながら30℃で5~24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。結果を表3に示す。分解5時間~24時間の範囲では、分解時間が長いほうがより強いビフィズス菌増殖促進活性が見られた。すなわち、本発明のPrtP酵素活性3.5Units/mlの場合には、分解5時間以上であれば強いビフィズス菌増殖促進作用が見られた。なお、PrtP酵素活性を強くした場合には、より短い分解時間でも充分なビフィズス菌増殖促進作用を有する分解物を得ることが出来た。
7). Effect of Milk Protein Degradation Time As described in 3 above, washed bacterial cells (PrtP enzyme-containing live cells) of Lactococcus lactis subspecies lactis JCM20101 strain were obtained.
Next, 3.5 unit / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and gently stirred at 30 ° C. for 5 to Hold for 24 hours. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 3. In the range of 5 hours to 24 hours after degradation, stronger bifidobacterial growth promoting activity was observed when the degradation time was longer. That is, in the case of the PrtP enzyme activity of 3.5 Units / ml according to the present invention, a strong bifidobacteria growth promoting action was observed if the degradation was 5 hours or longer. In addition, when the PrtP enzyme activity was strengthened, a degradation product having a sufficient bifidobacteria growth promoting action could be obtained even with a shorter degradation time.

Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003

8.乳タンパク質の分解温度の影響
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体(PrtP酵素含有生菌体)を得た。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液にPrtP酵素含有生菌体を、PrtP酵素単位として3.5Units/ml添加し、緩やかに撹拌しながら10~50℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。結果を表4に示す。分解温度50℃未満において、ビフィズス菌増殖促進活性が観察された。10℃~42℃ではビフィズス菌増殖促進活性が弱かったが、20~37℃では強い活性が見られ、特に30℃前後ではより強い活性が見られた。
8). Effect of Milk Protein Decomposition Temperature As described in 3 above, washed cells (PrtP enzyme-containing living cells) of Lactococcus lactis subspecies lactis JCM20101 strain were obtained.
Next, 3.5 unit / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein at 10 to 50 ° C. with gentle stirring. Hold for 24 hours. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 4. Bifidobacteria growth promoting activity was observed at a decomposition temperature of less than 50 ° C. The bifidobacteria growth promoting activity was weak at 10 to 42 ° C., but strong activity was observed at 20 to 37 ° C., and stronger activity was observed particularly at around 30 ° C.

Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004

9.PrtP酵素活性依存性
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体(PrtP酵素含有生菌体)を得た。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液にPrtP酵素含有生菌体を、PrtP酵素単位として0.01~10Units/ml添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。
 回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。結果を表5に示す。それぞれの分解物によるビフィズス菌増殖促進作用は、PrtP酵素活性に依存して強くなり、1Units/ml以上の酵素活性でより強いビフィズス菌増殖促進活性が見られた。
9. Dependence on PrtP enzyme activity As described in 3 above, washed cells (PrtP enzyme-containing live cells) of Lactococcus lactis sub-species lactis JCM20101 strain were obtained.
Next, 0.01 to 10 Units / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein at 30 ° C. with gentle stirring. Hold for 24 hours. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation.
The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 5. The bifidobacteria growth-promoting action by each degradation product became stronger depending on the PrtP enzyme activity, and a stronger bifidobacteria growth-promoting activity was observed with an enzyme activity of 1 Units / ml or more.

Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005

10.乳タンパク質分解時の基質濃度の影響
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体(PrtP酵素含有生菌体)を得た。
 次に、1~10%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液にPrtP酵素含有生菌体を、PrtP酵素単位として3.5Units/ml添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。結果を表6に示す。それぞれの分解物によるビフィズス菌増殖促進作用は、カゼインタンパク濃度0.5%以上でビフィズス菌増殖促進活性が見られ、特に1%以上の濃度でより強い活性が見られた。
10. Effect of Substrate Concentration on Milk Protein Degradation As described in 3 above, a washed cell (PrtP enzyme-containing live cell) of Lactococcus lactis sub-species lactis JCM20101 strain was obtained.
Next, 3.5 unit / ml of PrtP enzyme-containing living cells as a PrtP enzyme unit was added to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1-10% casein at 30 ° C. with gentle stirring. Hold for 24 hours. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 6. The bifidobacteria growth-promoting action of each degradation product was observed to be bifidobacteria growth-promoting activity at a casein protein concentration of 0.5% or more, and particularly stronger at a concentration of 1% or more.

Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006

11.乳タンパク質分解時のpHの影響
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体(PrtP酵素含有生菌体)を得た。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.0~8.0)溶液にPrtP酵素含有生菌体を、PrtP酵素単位として3.5Units/ml添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。
 回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により20分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。結果を表7に示す。pH6.0~8.0の範囲ではビフィズス菌増殖促進活性が見られ、特にpH6.5前後ではより強い活性が見られた。
11. Effect of pH on Milk Protein Degradation As described in 3 above, a washed cell (PrtP enzyme-containing live cell) of Lactococcus lactis subspecies lactis JCM20101 strain was obtained.
Next, PrtP enzyme-containing living cells were added to a 50 mM Tris-HCl buffer (pH 6.0 to 8.0) solution containing 1% casein as a PrtP enzyme unit at 3.5 Units / ml, and the mixture was gently stirred for 30 minutes. Hold at 24 ° C. for 24 hours. After the reaction, the mixture was sterilized by heating at 90 ° C. for 10 minutes, adjusted to pH 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation.
The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/20 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. The results are shown in Table 7. Bifidobacteria growth-promoting activity was observed in the range of pH 6.0 to 8.0, and stronger activity was observed particularly around pH 6.5.

Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007

12.PrtP酵素含有菌体破砕物による分解活性
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体を得た。続いて、この洗浄菌体を、超音波破砕機(BRANSON SONFIER 450)を用いて10分間以上の超音波破砕処理を行い、菌体を破砕した後、遠心分離(5000×g、10分)により未破砕菌体を除き、菌体破砕物を得た。なお、菌体破砕物に生きている細胞が存在しないことは、顕微鏡観察及びコロニー培養で確認した。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液に菌体破砕物をPrtP酵素単位として1Units/ml添加し、緩やかに撹拌しながら30℃で16時間保持した。反応後、90℃で10分間の加熱処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により50分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後の、培養後のビフィズス菌数及びpHを測定した。無添加の対照ではビフィズス菌が1.5×10CFU/ml、pHが6.18であったのに対して、上記菌体破砕物によるカゼイン分解物添加では、ビフィズス菌が2.8×10CFU/ml、pHが5.31まで低下した。これらの結果から、本発明の菌体破砕物が、ビフィズス菌に対する増殖促進性を有していることが明らかである。
12 Degradation activity by PrtP enzyme-containing disrupted cells As described in 3 above, washed cells of Lactococcus lactis sub-species lactis JCM20101 strain were obtained. Subsequently, the washed cells are subjected to ultrasonic crushing treatment for 10 minutes or more using an ultrasonic crusher (BRANSON SOFIER 450) to crush the cells, and then centrifuged (5000 × g, 10 minutes). Unbroken cells were removed to obtain crushed cells. In addition, it was confirmed by microscopic observation and colony culture that there were no living cells in the crushed cells.
Next, 1 Units / ml of the cell disruption was added as a PrtP enzyme unit to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and the mixture was kept at 30 ° C. for 16 hours with gentle stirring. After the reaction, heat treatment was performed at 90 ° C. for 10 minutes, the pH was adjusted to 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/50 volume by freeze concentration.
Each of the obtained casein degradation products was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the number of bifidobacteria after culture and the pH were measured. In the control without addition, Bifidobacterium was 1.5 × 10 7 CFU / ml and the pH was 6.18, whereas in the casein addition of the casein degradation product by the crushed cell body, Bifidobacterium was 2.8 ×. 10 8 CFU / ml, pH dropped to 5.31. From these results, it is clear that the disrupted bacterial cell of the present invention has a growth promoting property against Bifidobacterium.

13.PrtP酵素画分による分解活性
 上記3記載の通りに、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の洗浄菌体を得た。続いて、この洗浄菌体を、10mM EDTA・2Naを含む30mM MES-NaOH バッファー(pH6.5)に懸濁し、30℃で10分間保持した。その後急冷し、4℃の遠心分離(8500×g、10分)により遊離したPrtP酵素を含む上清液を得た。このPrtP酵素画分を、10mM塩化カルシウムを含む30mM MES-NaOH バッファー(pH6.5)で一晩透析した後、凍結濃縮により50分の1容量まで濃縮し、これをPrtP酵素画分とした。
 次に、1%カゼインを含む50mM Tris-HCl バッファー(pH6.5)溶液に、このPrtP酵素画分をPrtP酵素単位として1Units/ml添加し、緩やかに撹拌しながら30℃で16時間保持した。反応後、90℃で10分間の加熱処理を行い、塩酸でpH4.6に調整し、遠心分離により上清液を回収した。回収した上清液は水酸化ナトリウム水溶液でpH6.5に調整し、凍結濃縮により50分の1容量まで濃縮した。
 得られたそれぞれのカゼイン分解物を、上記5記載の方法でビフィズス菌増殖促進テストを行い、培養後のpHを測定した。無添加の対照ではビフィズス菌が1.75×10CFU/ml、pHが6.17であったのに対して、上記PrtP酵素画分によるカゼイン分解物添加では、ビフィズス菌が3.8×10CFU/ml、pHが5.34まで低下した。これらの結果から、本発明のPrtP酵素画分が、ビフィズス菌に対する増殖促進性を有していることが明らかである。
13. Degradation activity by PrtP enzyme fraction As described in 3 above, washed bacterial cells of Lactococcus lactis subspecies lactis JCM20101 strain were obtained. Subsequently, the washed cells were suspended in 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM EDTA · 2Na and kept at 30 ° C. for 10 minutes. Thereafter, it was rapidly cooled to obtain a supernatant containing PrtP enzyme released by centrifugation at 4 ° C. (8500 × g, 10 minutes). This PrtP enzyme fraction was dialyzed overnight against 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM calcium chloride, and then concentrated to 1/50 volume by freeze concentration, and this was used as the PrtP enzyme fraction.
Next, 1 unit / ml of this PrtP enzyme fraction was added as a PrtP enzyme unit to a 50 mM Tris-HCl buffer (pH 6.5) solution containing 1% casein, and the mixture was kept at 30 ° C. for 16 hours with gentle stirring. After the reaction, heat treatment was performed at 90 ° C. for 10 minutes, the pH was adjusted to 4.6 with hydrochloric acid, and the supernatant was collected by centrifugation. The collected supernatant was adjusted to pH 6.5 with an aqueous sodium hydroxide solution and concentrated to 1/50 volume by freeze concentration.
Each obtained casein degradation product was subjected to a bifidobacteria growth promotion test by the method described in 5 above, and the pH after the culture was measured. In the control without addition, Bifidobacteria was 1.75 × 10 7 CFU / ml and pH was 6.17, whereas in the case of the casein degradation product by the PrtP enzyme fraction, Bifidobacteria was 3.8 ×. 10 8 CFU / ml, pH dropped to 5.34. From these results, it is clear that the PrtP enzyme fraction of the present invention has growth promoting properties against Bifidobacteria.

 以上のように、PrtP酵素遺伝子を有するラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株及びラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株の生菌体、菌体破砕物、及びPrtP酵素画分による乳タンパク質分解物には、ビフィズス菌に対する増殖促進活性を有していることが明らかになった。また、その活性は、一般的な市販タンパク分解酵素による分解物より強いことが判明した。 As described above, the living cells of the Lactococcus lactis subspices cremolith NBRC100676 strain and Lactococcus lactis subspices lactis JCM20101 strain having the PrtP enzyme gene, and milk from the PrtP enzyme fraction It was revealed that the protein degradation product has a growth promoting activity against bifidobacteria. Moreover, it turned out that the activity is stronger than the decomposition product by a general commercial proteolytic enzyme.

 また、これらのPrtP酵素遺伝子を有するラクトコッカス・ラクチスは、ダイアセチル及びアセトインを生成しないため、これらの乳酸菌を用いることにより、風味の良い発酵物を製造し得ることも期待できる。
 さらに、高いビフィズス菌数を確保するために、ビフィズス菌スターターを、これらのPrtP酵素遺伝子を有するラクトコッカス・ラクチスの生菌体、菌体破砕物、又はPrtP酵素画分による乳タンパク質分解物を添加して発酵してもよい。
Moreover, since Lactococcus lactis having these PrtP enzyme genes does not produce diacetyl and acetoin, it can be expected that a savory fermented product can be produced by using these lactic acid bacteria.
Furthermore, in order to ensure a high number of Bifidobacterium, a Bifidobacterium starter is added to a living cell of Lactococcus lactis having these PrtP enzyme genes, a crushed cell of a cell, or a milk protein degradation product from a PrtP enzyme fraction. And may be fermented.

 次に実施例を示して本発明をさらに詳細に説明するが、本発明は以下の実施例に限定されるものではない。 Next, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to the following examples.

[実施例1] PrtP酵素含有生菌体によるカゼイン分解物の調製1
 まず、ラクトース及びグルコースを0.5%添加したDifco(登録商標)M17 Broth(Becton,Dickinson社製)100Lを、121℃で15分間殺菌し、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーを3L接種し、30℃で16時間培養した。続いて、遠心分離(8500×g、10分間、4℃)によりPrtP酵素含有生菌体を得た。
 次に、100Lの10%カゼイン(フォンテラ社製)溶液に得られたPrtP酵素含有生菌体を添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、凍結乾燥により10.5kgのカゼイン分解物を得た。
[Example 1] Preparation 1 of casein degradation product using live cells containing PrtP enzyme
First, 100 L of Difco (registered trademark) M17 Broth (Becton, Dickinson) added with 0.5% lactose and glucose was sterilized for 15 minutes at 121 ° C. 3 L of culture was inoculated and cultured at 30 ° C. for 16 hours. Subsequently, live cells containing PrtP enzyme were obtained by centrifugation (8500 × g, 10 minutes, 4 ° C.).
Next, the obtained PrtP enzyme-containing viable cells were added to 100 L of a 10% casein (fontera) solution, and kept at 30 ° C. for 24 hours with gentle stirring. After the reaction, heat sterilization treatment was performed at 90 ° C. for 10 minutes, and 10.5 kg of casein decomposition product was obtained by freeze-drying.

[実施例2] PrtP酵素含有生菌体によるカゼイン分解物の調製2
 ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーに代えて、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株のシードカルチャーを用いた以外は、実施例1と同様にしてカゼイン分解物11kgを得た。
[Example 2] Preparation 2 of casein degradation product using live cells containing PrtP enzyme
11 kg of casein degradation product was used in the same manner as in Example 1 except that the seed culture of Lactococcus lactis sub-species Lactis JCM20101 strain was used instead of the seed culture of Lactococcus lactis sub-species Cremolis NBRC100676 strain. Obtained.

[実施例3] PrtP酵素含有菌体破砕物によるカゼイン分解物の調製1
 まず、ラクトース及びグルコースを0.5%添加したDifco(登録商標)M17 Broth(Becton,Dickinson社製)100Lを、121℃で15分間殺菌し、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーを3L接種し、30℃で16時間培養した。続いて、遠心分離(8500×g、10分間、4℃)により菌体を得た。次に、この菌体を30分間の超音波処理(BRANSON SONFIER 450、10分間破砕処理)により菌体を破砕した後、遠心分離(8500×g、10分、4℃)により未破砕菌体を除き、凍結濃縮し、PrtP酵素含有菌体破砕物を得た。
 次に、100Lの10%カゼイン(フォンテラ社製)溶液に得られたPrtP酵素含有菌体破砕物を添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、凍結乾燥により10kgのカゼイン分解物を得た。
[Example 3] Preparation 1 of casein degradation product using PrtP enzyme-containing crushed cells
First, 100 L of Difco (registered trademark) M17 Broth (Becton, Dickinson) added with 0.5% lactose and glucose was sterilized for 15 minutes at 121 ° C. 3 L of culture was inoculated and cultured at 30 ° C. for 16 hours. Subsequently, the cells were obtained by centrifugation (8500 × g, 10 minutes, 4 ° C.). Next, the cells were crushed by ultrasonic treatment (BRANSON SOFIER 450, 10 minutes crushing) for 30 minutes, and then centrifuged (8500 × g, 10 minutes, 4 ° C.) to remove unbroken cells. The PrtP enzyme-containing microbial cell disruption product was obtained.
Next, the obtained PrtP enzyme-containing microbial cell disruption was added to 100 L of 10% casein (Fontera) solution, and kept at 30 ° C. for 24 hours with gentle stirring. After the reaction, heat sterilization treatment was performed at 90 ° C. for 10 minutes, and 10 kg of casein decomposition product was obtained by freeze-drying.

[実施例4] PrtP酵素含有菌体破砕物によるカゼイン分解物の調製2
 ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーに代えて、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株のシードカルチャーを用いた以外は、実施例3と同様にしてカゼイン分解物10.1kgを得た。
[Example 4] Preparation 2 of casein degradation product using crushed cell containing PrtP enzyme
9. Casein degradation product in the same manner as in Example 3 except that the seed culture of Lactococcus lactis subspices lactis JCM20101 strain was used instead of the seed culture of Lactococcus lactis subspecies Cremolis NBRC100676 strain. 1 kg was obtained.

[実施例5] PrtP酵素画分によるカゼイン分解物の調製1
 まず、ラクトース及びグルコースを0.5%添加したDifco(登録商標)M17 Broth(Becton,Dickinson社製)100Lを、121℃で15分間殺菌し、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーを3L接種し、30℃で16時間培養した。続いて、遠心分離(8500×g、10分間、4℃)により菌体を得た。
 次に、この菌体を、5Lの10mM EDTA・2Naを含む30mM MES-NaOH バッファー(pH6.5)に懸濁し、30℃で10分間保持した。その後急冷し、遠心分離(8500×g、10分間、4℃)により遊離したPrtP酵素を含む上清液を得た。この上清液を、10mM塩化カルシウムを含む30mM MES-NaOH buffer(pH6.5)で一晩透析し、凍結濃縮により2L容量まで濃縮し、PrtP酵素画分を得た。
 次に、100Lの10%カゼイン(フォンテラ社製)溶液に得られたPrtP酵素画分を添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間殺菌の過熱処理を行い、凍結乾燥により10.1kgのカゼイン分解物を得た。
[Example 5] Preparation 1 of casein degradation product by PrtP enzyme fraction 1
First, 100 L of Difco (registered trademark) M17 Broth (Becton, Dickinson) added with 0.5% lactose and glucose was sterilized for 15 minutes at 121 ° C. 3 L of culture was inoculated and cultured at 30 ° C. for 16 hours. Subsequently, the cells were obtained by centrifugation (8500 × g, 10 minutes, 4 ° C.).
Next, this microbial cell was suspended in 30 mM MES-NaOH buffer (pH 6.5) containing 5 L of 10 mM EDTA · 2Na and kept at 30 ° C. for 10 minutes. Thereafter, it was rapidly cooled, and a supernatant liquid containing PrtP enzyme released by centrifugation (8500 × g, 10 minutes, 4 ° C.) was obtained. The supernatant was dialyzed overnight against 30 mM MES-NaOH buffer (pH 6.5) containing 10 mM calcium chloride, and concentrated to 2 L by freeze concentration to obtain a PrtP enzyme fraction.
Next, the obtained PrtP enzyme fraction was added to 100 L of 10% casein (Fontera) solution, and the mixture was kept at 30 ° C. for 24 hours with gentle stirring. After the reaction, sterilization was performed at 90 ° C. for 10 minutes, and freeze-dried to obtain 10.1 kg of casein degradation product.

[実施例6] PrtP酵素画分によるカゼイン分解物の調製2
 ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーに代えて、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株のシードカルチャーを用いた以外は、実施例5と同様にしてカゼイン分解物10.1kgを得た。
[Example 6] Preparation 2 of casein degradation product by PrtP enzyme fraction 2
9. Casein degradation product in the same manner as in Example 5 except that the seed culture of Lactococcus lactis subspices lactis JCM20101 strain was used instead of the seed culture of Lactococcus lactis subspecies Cremolis NBRC100676 strain. 1 kg was obtained.

[実施例7] PrtP酵素含有生菌体によるカゼイン分解物によるビフィズス菌スターターの調製
 まず、上記実施例1記載の方法に調製したカゼイン分解物を0.1%(W/W)となるように添加した10%(W/W)脱脂粉乳を含む培地1000mLを、90℃で30分間殺菌した。この殺菌済みの培地に、ビフィドバクテリウム・ロンガムATCC BAA-999株のシードカルチャーを100mL接種し、37℃で5時間培養し、カルチャーを得た。得られたカルチャーのpHは4.7で、ビフィズス菌数は1.2×10CFU/gであった。
[Example 7] Preparation of bifidobacteria starter by casein degradation product from PrtP enzyme-containing living cells First, the casein degradation product prepared by the method described in Example 1 is 0.1% (W / W). 1000 mL of the medium containing the added 10% (W / W) nonfat dry milk was sterilized at 90 ° C. for 30 minutes. To this sterilized medium, 100 mL of a seed culture of Bifidobacterium longum ATCC BAA-999 strain was inoculated and cultured at 37 ° C. for 5 hours to obtain a culture. The pH of the obtained culture was 4.7, and the number of bifidobacteria was 1.2 × 10 9 CFU / g.

[実施例8] PrtP酵素含有生菌体によるカゼイン分解物による整腸剤の調製
 乾燥殺菌した澱粉59kg、砂糖40kgに、上記実施例2記載の方法に調製したカゼイン分解物1kgを加えて、均一に混合し、整腸剤約100kgを得た。
[Example 8] Preparation of an intestinal preparation by casein degradation product using PrtP enzyme-containing living cells [0109] 1 kg of casein degradation product prepared by the method described in Example 2 above was added to 59 kg of dry sterilized starch and 40 kg of sugar, and mixed uniformly. As a result, about 100 kg of an intestinal preparation was obtained.

[実施例9] PrtP酵素含有生菌体によるカゼイン分解物による飲料の調製
 りんごジュース100kgに、上記実施例1記載の方法に調製したカゼイン分解物1kgを加えて、140℃で2秒間殺菌し、ペットボトルに充填し、本発明の乳タンパク質分解物含有飲料を得た。この飲料は、ビフィズス菌増殖作用が期待できる飲料である。
[Example 9] Preparation of beverage by casein degradation product using PrtP enzyme-containing living cells 1 kg of casein degradation product prepared by the method described in Example 1 above was added to 100 kg of apple juice, and sterilized at 140 ° C for 2 seconds. Filled into a PET bottle, the milk protein decomposed product-containing beverage of the present invention was obtained. This beverage is a beverage that can be expected to have a bifidobacteria growth action.

[実施例10] PrtP酵素含有生菌体によるカゼイン分解物による飼料の調製
 脱脂粉乳100kgに、上記実施例2記載の方法に調製したカゼイン分解物1kgを加えて、均一に混合し、本発明の乳タンパク質分解物含有飼料として約100kgを得た。
[Example 10] Preparation of feed by casein degradation product with live PrtP enzyme-containing cells 1 kg of casein degradation product prepared by the method described in Example 2 above is added to 100 kg of skim milk powder and mixed uniformly. About 100 kg was obtained as a feed containing a milk protein degradation product.

[実施例11] PrtP酵素含有生菌体によるトータルミルクプロテイン分解物の調製
 実施例1と同様にして、ラクトコッカス・ラクチス・サブスピーシーズ・クレモリスNBRC100676株のシードカルチャーに代えて、ラクトコッカス・ラクチス・サブスピーシーズ・ラクチスJCM20101株のシードカルチャーを用いて、PrtP酵素含有生菌体を得た。
 次に、100Lの10%トータルミルクプロテイン(ミライ社製)溶液に、得られたPrtP酵素含有生菌体を添加し、緩やかに撹拌しながら30℃で24時間保持した。反応後、90℃で10分間の加熱殺菌処理を行い、凍結乾燥により10.2kgのトータルミルクプロテイン分解物を得た。
Example 11 Preparation of Total Milk Protein Degradation Product Using PrtP Enzyme-Containing Live Bacteria In the same manner as in Example 1, instead of the seed culture of Lactococcus lactis subspecies cremolith NBRC100676 strain, Lactococcus lactis PrtP enzyme-containing viable cells were obtained using the seed culture of Subspecies lactis JCM20101 strain.
Next, the obtained PrtP enzyme-containing viable cells were added to 100 L of a 10% total milk protein (Mirai) solution, and kept at 30 ° C. for 24 hours with gentle stirring. After the reaction, heat sterilization treatment was performed at 90 ° C. for 10 minutes, and 10.2 kg of total milk protein degradation product was obtained by lyophilization.

 本発明の乳タンパク質分解物は、ビフィズス菌増殖促進活性を有するため、ビフィズス菌含有発酵乳等のビフィズス菌含有飲食品等の製造分野で利用が可能である。また、本発明の乳タンパク質分解物は、牛乳等の乳タンパク質を原料とするため、本発明の乳タンパク質分解物を用いることにより、乳製品のみでビフィズス菌含有製品の設計が可能となり有用であるため、特に乳製品の分野で利用が可能である。 Since the milk protein degradation product of the present invention has bifidobacteria growth-promoting activity, it can be used in the field of manufacturing foods and beverages containing bifidobacteria such as fermented milk containing bifidobacteria. In addition, since the milk protein degradation product of the present invention uses milk protein such as cow milk as a raw material, the use of the milk protein degradation product of the present invention makes it possible to design a bifidobacteria-containing product using only a milk product. Therefore, it can be used particularly in the field of dairy products.

Claims (13)

 細胞壁局在性タンパク質分解酵素 (cell wall-enveloped proteinase、PrtP)を有する乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画された前記酵素画分からなる群より選択される1以上を用いて、乳タンパク質を加水分解することにより得られることを特徴とする乳タンパク質分解物。 Selected from the group consisting of living lactic acid bacteria having cell wall-localized protease (PrtP), disrupted lactic acid bacteria, and enzyme fractions fractionated from the lactic acid bacteria A milk protein degradation product obtained by hydrolyzing milk protein using one or more.  前記乳酸菌がラクトコッカス・ラクチス(Lactococcus lactis)である、請求項1記載の乳タンパク質分解物。 The milk protein degradation product according to claim 1, wherein the lactic acid bacterium is Lactococcus lactis.  前記ラクトコッカス・ラクチスが、キシロース資化性を有さず、かつ、ダイアセチル及びアセトインを生成しないことを特徴とする、請求項2記載の乳タンパク質分解物。 The milk protein degradation product according to claim 2, wherein the Lactococcus lactis does not have xylose utilization and does not produce diacetyl and acetoin.  前記乳タンパク質が、カゼイン又はトータルミルクプロテインであることを特徴とする、請求項1~3のいずれか一項に記載の乳タンパク質分解物。 The milk protein degradation product according to any one of claims 1 to 3, wherein the milk protein is casein or total milk protein.  前記加水分解が、pH6.0~8.0に調整された乳タンパク質を基質として、20~37℃、乳タンパク質濃度が0.5重量%以上の条件で行われることを特徴とする、請求項1~4のいずれか一項に記載の乳タンパク質分解物。 The hydrolysis is performed under the conditions of 20 to 37 ° C and a milk protein concentration of 0.5% by weight or more using a milk protein adjusted to pH 6.0 to 8.0 as a substrate. The milk protein degradation product according to any one of 1 to 4.  細胞壁局在性タンパク質分解酵素 (cell wall-enveloped proteinase、PrtP)を有する乳酸菌の生菌体、前記乳酸菌の菌体破砕物、及び前記乳酸菌から分画された前記酵素画分からなる群より選択される1以上を用いて、乳タンパク質を加水分解することを特徴とする、乳タンパク質分解物の製造方法。 Selected from the group consisting of living lactic acid bacteria having cell wall-localized protease (PrtP), disrupted lactic acid bacteria, and enzyme fractions fractionated from the lactic acid bacteria A method for producing a milk protein degradation product, comprising hydrolyzing milk protein using one or more.  前記乳酸菌がラクトコッカス・ラクチス(Lactococcus lactis)である、請求項6記載の乳タンパク質分解物の製造方法。 The method for producing a milk protein degradation product according to claim 6, wherein the lactic acid bacterium is Lactococcus lactis.  前記ラクトコッカス・ラクチスが、キシロース資化性を有さず、かつ、ダイアセチル及びアセトインを生成しないことを特徴とする、請求項7記載の乳タンパク質分解物の製造方法。 The method for producing a milk protein degradation product according to claim 7, wherein the Lactococcus lactis does not have xylose utilization and does not produce diacetyl and acetoin.  前記乳タンパク質が、カゼイン又はトータルミルクプロテインであることを特徴とする、請求項6~8のいずれか一項に記載の乳タンパク質分解物の製造方法。 The method for producing a milk protein degradation product according to any one of claims 6 to 8, wherein the milk protein is casein or total milk protein.  前記加水分解が、pH6.0~8.0に調整された乳タンパク質を基質として、20~37℃、乳タンパク質濃度が0.5重量%以上の条件で行われることを特徴とする請求項6~9のいずれか一項に記載の乳タンパク質分解物の製造方法。 7. The hydrolysis is performed under the conditions of 20 to 37 ° C. and a milk protein concentration of 0.5% by weight or more using a milk protein adjusted to pH 6.0 to 8.0 as a substrate. 10. The method for producing a milk protein degradation product according to any one of 1 to 9.  請求項1~5のいずれか一項に記載の乳タンパク質分解物を有効成分とするビフィズス菌増殖促進剤。 A bifidobacteria growth promoter comprising the milk protein degradation product according to any one of claims 1 to 5 as an active ingredient.  前記ビフィズス菌がビフィドバクテリウム・ロンガム(Bifidobacterium longum)である請求項11記載のビフィズス菌増殖促進剤。 The bifidobacteria growth promoter according to claim 11, wherein the bifidobacteria is Bifidobacterium longum.  前記ビフィドバクテリウム・ロンガムの菌株が、ビフィドバクテリウム・ロンガムATCC BAA-999株及び/又はビフィドバクテリウム・ロンガム タイプストレインATCC15700株である請求項12記載のビフィズス菌増殖促進剤。 The Bifidobacterium longum strain according to claim 12, wherein the strain of Bifidobacterium longum is Bifidobacterium longum ATCC BAA-999 and / or Bifidobacterium longum type strain ATCC15700.
PCT/JP2009/056803 2008-06-11 2009-04-01 Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent Ceased WO2009150888A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010516787A JPWO2009150888A1 (en) 2008-06-11 2009-04-01 Milk protein degradation product, milk protein degradation product production method and bifidobacteria growth promoter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008-152951 2008-06-11
JP2008152951 2008-06-11

Publications (1)

Publication Number Publication Date
WO2009150888A1 true WO2009150888A1 (en) 2009-12-17

Family

ID=41416599

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/056803 Ceased WO2009150888A1 (en) 2008-06-11 2009-04-01 Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent

Country Status (2)

Country Link
JP (1) JPWO2009150888A1 (en)
WO (1) WO2009150888A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009296910A (en) * 2008-06-11 2009-12-24 Morinaga Milk Ind Co Ltd Bifidobacterium bacillus-containing composition and method for producing the bifidobacterium bacillus-containing composition
CN112205471A (en) * 2020-10-16 2021-01-12 光明乳业股份有限公司 Bifidobacterium bifidum fermented milk and preparation method thereof
CN113999884A (en) * 2021-11-05 2022-02-01 南京康瑞生物科技有限公司 Preparation method of turtle bioactive peptide

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AZUMA, N. ET AL.: "Bifidus Growth-promoting Activity of a Glycomacropeptide Derived from Human K-Casein.", AGRICULTURAL AND BIOLOGICAL CHEMISTRY, vol. 48, no. 8, 1984, pages 2159 - 2162 *
JUILLARD, V. ET AL.: "The extracellular PI-type proteinase of Lactococcus lactis hydrolyzes beta-casein into more than one hundred different oligopeptides.", J. BACTERIOLOGY, vol. 177, no. 12, 1995, pages 3472 - 3478 *
KEIJI IGOSHI ET AL.: "Nhuhakko Shokuhin ni Okeru Tanpakushitsu Bunkai", MILK SCIENCE, vol. 53, no. 1, 2004, pages 1 - 8 *
KUNJI, E. R. S. ET AL.: "The proteolytic systems of lactic acid bacteria.", ANTONIE VAN LEEUWENHOEK, vol. 70, 1996, pages 187 - 221 *
POCH, M. ET AL.: "A. BEZKOROVAINY, Bovine milk kappa- casein trypsin digest is a growth enhancer for the genus Bifidobacterium.", J. AGRICULTURAL AND FOOD CHEMISTRY, vol. 39, 1991, pages 73 - 77 *
PROULX, M. ET AL.: "Effect of casein hydrolysates on the growth of bifidobacteria.", LAIT, vol. 72, 1992, pages 393 - 404 *
REIDO, J. R. ET AL.: "Specificity of hydrolysis of bovine kappa-casein by cell envelope-associated proteinases from Lactococcus lactis strains.", APPLIED AND ENVIROMENTAL MICROBIOLOGY, vol. 60, no. 3, 1994, pages 801 - 806 *
SAVIJOKI, K. ET AL.: "Proteolytic systems of lactic acid bacteria.", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 71, 2006, pages 394 - 406 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009296910A (en) * 2008-06-11 2009-12-24 Morinaga Milk Ind Co Ltd Bifidobacterium bacillus-containing composition and method for producing the bifidobacterium bacillus-containing composition
CN112205471A (en) * 2020-10-16 2021-01-12 光明乳业股份有限公司 Bifidobacterium bifidum fermented milk and preparation method thereof
CN113999884A (en) * 2021-11-05 2022-02-01 南京康瑞生物科技有限公司 Preparation method of turtle bioactive peptide
CN113999884B (en) * 2021-11-05 2023-09-12 南京康瑞生物科技有限公司 Preparation method of turtle bioactive peptide

Also Published As

Publication number Publication date
JPWO2009150888A1 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
Champagne et al. Challenges in the addition of probiotic cultures to foods
JP4802216B2 (en) Bifidobacterium-containing composition and method for producing Bifidobacterium-containing composition
JP4448896B2 (en) Method for producing fermented milk
JP6193439B2 (en) Lactobacillus lactic acid bacteria growth promoter and / or survival improver
Yonezawa et al. Improved growth of bifidobacteria by cocultivation with Lactococcus lactis subspecies lactis
Zago et al. Functional characterization and immunomodulatory properties of Lactobacillus helveticus strains isolated from Italian hard cheeses
US20240032553A1 (en) Frozen enzyme pellets
Koutinas Fermented dairy products
MX2012009975A (en) Method for producing fermented food containing bifidobacterium bacteria.
WO2009150888A1 (en) Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent
Banina et al. Characterization of natural isolate Lactobacillus acidophilus BGRA43 useful for acidophilus milk production
JP7680201B2 (en) DPP-4 Inhibitory Composition
JP2017514527A (en) Yogurt production
JP4307026B2 (en) Lactic acid bacteria growth promoter and process for producing the same
JP2023014396A (en) Bifidobacteria survival-improving composition
JP2015167474A (en) Lactobacillus lactic acid bacterium culture food grade medium, cultivation method of lactobacillus lactic acid bacterium and producing method of lactobacillus lactic acid bacterium culture
JP2006014654A (en) Antibody-containing food
WO2005097972A1 (en) Medium for lactic acid bacteria
JP2015050993A (en) Gastrointestinal tract and feces-derived lactobacilli culture milk or soybean milk-derived composition, culture or fermentation material and lactic fermentation product
CN117916358A (en) Lactic acid bacteria, lactic acid bacteria starter, fermented milk, method for producing fermented milk, and method for screening lactic acid bacteria
CN119032163A (en) Method for preparing lactic acid bacteria culture, its product and culture medium
BEERMANN et al. LACTIC ACID BACTERIA AND ASSOCIATED PRODUCT CHARACTERISTICS WITHIN MILK FERMENTATION
Smith The optimisation of accelerated yogurt production
PL241893B1 (en) Method for selecting proteolytic microorganisms, method for producing whey protein hydrolyzate containing bioactive peptides and whey protein hydrolyzate
JP2000041665A (en) Lactobacillus propagation composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09762319

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010516787

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09762319

Country of ref document: EP

Kind code of ref document: A1